<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">98634</article-id><article-id pub-id-type="doi">10.7554/eLife.98634</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.98634.4</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Multifaceted role of galanin in brain excitability</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rieser</surname><given-names>Nicolas N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ronchetti</surname><given-names>Milena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hotz</surname><given-names>Adriana Lea Lea</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Neuhauss</surname><given-names>Stephan CF</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9615-480X</contrib-id><email>stephan.neuhauss@mls.uzh.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>Department of Molecular Life Sciences, University of Zurich</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05a28rw58</institution-id><institution>Life Science Zürich Graduate School</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Scharfman</surname><given-names>Helen E</given-names></name><role>Reviewing Editor</role><aff><institution>Nathan Kline Institute</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Huguenard</surname><given-names>John R</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Functional Genomics Center Zurich (FGCZ), University of Zurich, Switzerland</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>04</day><month>07</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP98634</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-04-10"><day>10</day><month>04</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-04-05"><day>05</day><month>04</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.04.05.588285"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-07-15"><day>15</day><month>07</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98634.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-03-26"><day>26</day><month>03</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98634.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-05-30"><day>30</day><month>05</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98634.3"/></event></pub-history><permissions><copyright-statement>© 2024, Rieser et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Rieser et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-98634-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-98634-figures-v1.pdf"/><abstract><p>Galanin is a neuropeptide, which is critically involved in homeostatic processes like controlling arousal, sleep, and regulation of stress. This extensive range of functions aligns with implications of galanin in diverse pathologies, including anxiety disorders, depression, and epilepsy. Here, we investigated the regulatory function of galanin on whole-brain activity in larval zebrafish using wide-field Ca<sup>2+</sup> imaging. Combining this with genetic perturbations of galanin signaling and pharmacologically increasing neuronal activity, we are able to probe actions of galanin across the entire brain. Our findings demonstrate that under unperturbed conditions and during epileptic seizures, galanin exerts a sedative influence on the brain, primarily through the galanin receptor 1 a (<italic>galr1a</italic>). However, exposure to acute stressors like pentylenetetrazole (PTZ) compromises galanin’s sedative effects, leading to overactivation of the brain and increased seizure occurrence. Interestingly, galanin’s impact on seizures appears to be bidirectional, as it can both decrease seizure severity and increase seizure occurrence, potentially through different galanin receptor subtypes. This nuanced interplay between galanin and various physiological processes underscores its significance in modulating stress-related pathways and suggests its potential implications for neurological disorders such as epilepsy. Taken together, our data sheds light on a multifaceted role of galanin, where galanin regulates whole-brain activity but also shapes acute responses to stress.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>galanin</kwd><kwd>epilepsy</kwd><kwd>glutamate transporter</kwd><kwd>brain imaging</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>310030_204648</award-id><principal-award-recipient><name><surname>Neuhauss</surname><given-names>Stephan CF</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>310030_135598</award-id><principal-award-recipient><name><surname>Neuhauss</surname><given-names>Stephan CF</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Forschungskredit Candoc</institution></institution-wrap></funding-source><award-id>K-74417-04-01</award-id><principal-award-recipient><name><surname>Rieser</surname><given-names>Nicolas N</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The neuropeptide galanin modulates whole-brain activity and stress responses in zebrafish, revealing a complex, receptor-dependent role in seizure regulation with implications for epilepsy, and related neurological disorders.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Similar to classic neurotransmitters, neuropeptides are chemical messengers that are mainly synthesized and released by neurons. In contrast to conventional neurotransmitters, neuropeptides are amino acid chains between 3 and 36 amino acids in length. While classic neurotransmitters are primarily stored in synaptic vesicles, neuropeptides are predominantly stored in large dense-core vesicles (LDCV) and are mostly released during neuronal bursts or high-frequency firing (<xref ref-type="bibr" rid="bib38">Lang et al., 2015</xref>; <xref ref-type="bibr" rid="bib70">van den Pol, 2012</xref>). Neuropeptides play a crucial role in modulating neuronal activity and regulating various aspects of neural network function. They act as neuromodulators, exerting long-lasting effects on neuronal excitability, synaptic transmission, and plasticity (<xref ref-type="bibr" rid="bib38">Lang et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Purves et al., 2019</xref>). By influencing the balance between excitatory and inhibitory inputs to neurons, neuropeptides can shape network dynamics and information processing. This is achieved through their interactions with specific receptors and signaling pathways, allowing for precise modulation and optimization of neural activity in response to changing conditions (<xref ref-type="bibr" rid="bib70">van den Pol, 2012</xref>). Overall, neuropeptides play a pivotal role in orchestrating the complex activity of neuronal networks and maintaining homeostasis within the central nervous system. Elevated neuronal activity is often accompanied by shifts in neuropeptide transcription rates through a phenomenon known as ‘stimulus-secretion-synthesis coupling’ (<xref ref-type="bibr" rid="bib11">Douglas, 1968</xref>; <xref ref-type="bibr" rid="bib48">MacArthur and Eiden, 1996</xref>). This intricate interplay between neuropeptide release and biosynthesis likely serves as a crucial mechanism for replenishing neuropeptide stores, given the absence of a mechanism for neuropeptide uptake post-release and their degradation by extracellular peptidases. Furthermore, neuropeptides are well known to contact neurons via volume transmission, where extrasynaptically secreted molecules activate receptors on neurons synaptically unconnected to the releasing neuron. This leads to signal transmission across considerable distances, extending up to multiple microns, targeting multiple neurons in different regions of the brain (<xref ref-type="bibr" rid="bib38">Lang et al., 2015</xref>; <xref ref-type="bibr" rid="bib70">van den Pol, 2012</xref>; <xref ref-type="bibr" rid="bib26">Jan and Jan, 1982</xref>; <xref ref-type="bibr" rid="bib4">Atkinson et al., 2021</xref>; <xref ref-type="bibr" rid="bib54">Nässel, 2009</xref>; <xref ref-type="bibr" rid="bib64">Ripoll-Sánchez et al., 2023</xref>).</p><p>Galanin is such a neuropeptide, which is expressed predominantly in the hypothalamus, the center of homeostatic regulation in the brain. Galanin is highly involved in homeostatic processes like controlling arousal and sleep (<xref ref-type="bibr" rid="bib71">Woods et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Gaus et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Kroeger et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">McGinty and Szymusiak, 2003</xref>; <xref ref-type="bibr" rid="bib47">Ma et al., 2019</xref>), but has been shown to regulate stress (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Juhasz et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Hökfelt et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Khoshbouei et al., 2002</xref>; <xref ref-type="bibr" rid="bib56">Picciotto et al., 2010</xref>). Moreover, research has demonstrated that galanin-producing neurons in the hypothalamus play a role in regulating both food intake (<xref ref-type="bibr" rid="bib65">Schick et al., 1993</xref>; <xref ref-type="bibr" rid="bib1">Adams et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Qualls-Creekmore et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Laque et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Leibowitz et al., 1998</xref>) and parental behavior (<xref ref-type="bibr" rid="bib30">Kohl et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Wu et al., 2014</xref>) in rodents. This extensive range of functions aligns with implications of galanin in diverse pathologies, including anxiety disorders, depression, and epilepsy (<xref ref-type="bibr" rid="bib38">Lang et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Juhasz et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Hökfelt et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Kovac and Walker, 2013</xref>; <xref ref-type="bibr" rid="bib41">Lerner et al., 2008</xref>; <xref ref-type="bibr" rid="bib51">McColl et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Fetissov et al., 2003</xref>; <xref ref-type="bibr" rid="bib25">Jacoby et al., 2002</xref>; <xref ref-type="bibr" rid="bib50">Mazarati et al., 2000</xref>; <xref ref-type="bibr" rid="bib12">Drexel et al., 2018</xref>). We found an upregulation of galanin in a recently described novel model of epilepsy (<xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>) that let us hypothesize that galanin may mediate a neuroprotective, net inhibitory effect on epileptic brains.</p><p>Here, we investigated the regulatory function of galanin on whole-brain activity in larval zebrafish (<italic>Danio rerio</italic>). Leveraging the transparency of zebrafish during their larval stages, a characteristic that facilitates live imaging, we utilized basic wide-field Ca<sup>2+</sup> imaging methods. Combining this with genetic perturbation of galanin and pharmacologically increasing neuronal activity, we were able to delve into the actions of galanin across the entire brain.</p><p>Our findings demonstrate that, under unperturbed conditions and during epileptic seizures, galanin exerts a net inhibitory influence on the brain, which is likely governed by <italic>galanin receptor 1</italic> a (<italic>galr1a</italic>). However, when faced with an acute stressor like pentylenetetrazole (PTZ), the typically sedative effects of galanin are substantially compromised. We found that exposure to this acute central nervous system stressor results in a galanin-dependent overactivation of the brain that overrides most of galanins sedating actions and increases the occurrence of epileptic seizures. Taken together, our data sheds light on a multifaceted role of galanin, where galanin regulates whole-brain activity but also shapes acute responses to stress.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>gal</italic> expression correlates with whole-brain activity</title><p>In prior work, we introduced a novel epilepsy model characterized by recurrent epileptic seizures and interictal neuronal hypoactivity (<xref ref-type="fig" rid="fig1">Figure 1A-D</xref>: <xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>). The unexpected observation of locomotor and neuronal hypoactivity in this model stands in contrast to most existing studies in zebrafish that report hyperactivity in epileptic animals (<xref ref-type="bibr" rid="bib7">Baraban et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Hortopan et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Baraban et al., 2005</xref>). Intriguingly, recent investigations have demonstrated that overexpression of galanin induces locomotory hypoactivity in zebrafish models (<xref ref-type="bibr" rid="bib71">Woods et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>). To explore the potential involvement of galanin in the hypoactivity observed in <italic>eaat2a</italic> mutants, we conducted qPCR analysis on 5 dpf (days post fertilization) larval brains (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The results revealed a significant 15.4-fold increase in galanin expression compared to wild-type siblings, suggesting an involvement of galanin in the interictal hypoactivity observed in <italic>eaat2a</italic> mutants. Furthermore, recent findings have shed light on the role of galanin in pharmacologically induced rebound sleep (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>). Additionally, it was demonstrated that increasing short-term neuronal activity results in subsequent inactivity that is dependent on galanin (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>). To explore whether the application of GABA<sub>A</sub> receptor antagonist PTZ would also lead to a temporary decrease in whole-brain activity, we exposed 5 dpf larvae to 20 mM PTZ for 1 h, followed by a 2 hr washout period before undergoing Ca<sup>2+</sup> imaging. Remarkably, while PTZ increases swimming activity and induces seizure-like behavior during acute drug exposure (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>; <xref ref-type="bibr" rid="bib5">Baraban et al., 2005</xref>; <xref ref-type="bibr" rid="bib6">Baraban et al., 2007</xref>), there was a significant reduction in brain activity during PTZ rebound (<xref ref-type="fig" rid="fig1">Figure 1G-K</xref>), which was correlated with an increase in galanin expression by 2.5-fold (<xref ref-type="fig" rid="fig1">Figure 1I</xref>) compared with non-PTZ-treated larvae. Notably, large Ca<sup>2+</sup> fluctuations (ΔF/F<sub>0</sub> &gt;10%) decreased in frequency (<xref ref-type="fig" rid="fig1">Figure 1J</xref>), and decreased in amplitude (<xref ref-type="fig" rid="fig1">Figure 1K</xref>), while their duration increased (<xref ref-type="fig" rid="fig1">Figure 1L</xref>) compared to non-PTZ-treated larvae. For small Ca<sup>2+</sup> fluctuations (ΔF/F<sub>0</sub> &gt;5) the frequency also decreased (<xref ref-type="fig" rid="fig1">Figure 1J</xref>), while their amplitude and duration were not affected (<xref ref-type="fig" rid="fig1">Figure 1K and L</xref>). Together, our results illustrate that the expression of galanin rises in reaction to seizure-like activity in two separate seizure models and is correlated with an overall decrease in whole-brain activity.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>gal</italic> expression correlates with whole-brain activity.</title><p>(<bold>A</bold>) Representative calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf control (<italic>eaat2a<sup>+/+</sup></italic>) larva (blue, top) and <italic>eaat2a<sup>-/-</sup></italic> mutant without seizure activity (red, bottom). (<bold>B</bold>) Area under the curve (AUC) calculated and averaged over two 5 min time windows per animal and normalized to control (n control = 25; n <italic>eaat2a<sup>-/-</sup></italic> = 12). (<bold>C</bold>) Galanin transcript levels in pools of control vs. <italic>eaat2a<sup>-/-</sup></italic> brains (n = 3). (<bold>D</bold>) Number of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right). (<bold>E</bold>) Average amplitude of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>F</bold>) Average duration of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>G</bold>) Representative calcium signals (<italic>elavl3:GCaMP6f</italic>) recorded across the brain of 5 dpf control (blue, top) and larvae 2 hr after pentylenetetrazole (PTZ) exposure (PTZ rebound) (magenta, bottom). (<bold>H</bold>) AUC calculated over 1 hr recording, normalized to control (n control = 21; n PTZ rebound = 21). (<bold>I</bold>) Galanin transcript levels in pools of control vs. PTZ rebound brains (n = 3). (<bold>G</bold>) Number of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right). (<bold>J</bold>) Average amplitude of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>K</bold>) Average duration of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. Significance levels: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05, ns = not significant (p&gt;0.05), Wilcoxon-Mann-Whitney test (<bold>B, E, H, J, K</bold>), negative binomial regression (<bold>D, I</bold>), Student’s t-test (<bold>C, F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98634-fig1-v1.tif"/></fig></sec><sec id="s2-2"><title><italic>gal</italic> controls whole-brain activity</title><p>To investigate if galanin by itself is able to reduce whole-brain activity, we employed a transgenic approach by using <italic>hsp70l:gal (</italic><xref ref-type="bibr" rid="bib71">Woods et al., 2014</xref>) expressing larvae. These transgenic fish express galanin under the control of the heat shock promoter <italic>hsp70l</italic>, enabling the induction of galanin expression by upregulating transcripts by over 300 fold (<xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>). Attempts to induce galanin overexpression through heat shock were discontinued due to a notable impact on the brain activity of wild-type larvae compared to non-exposed wild-type larvae (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Yet, considering that <italic>hsp70l:gal</italic> larvae already display a basal elevation of galanin transcripts by approximately eightfold (<xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>), comparable with the upregulation seen in <italic>eaat2a<sup>-/-</sup></italic> mutants and PTZ rebound (<xref ref-type="fig" rid="fig1">Figure 1C and I</xref>), we chose to use larvae without inducing transcription via heat shock. We performed Ca<sup>2+</sup> imaging and found that indeed elevated expression of galanin in <italic>hsp70l:gal</italic> larvae leads to a decrease in whole-brain activity (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) compared to wild-type siblings. We detected a reduction in frequency of Ca<sup>2+</sup> fluctuations for larger Ca<sup>2+</sup> events and a reduction in their amplitude (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>), mirroring our earlier findings in the PTZ rebound (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref>). Notably, <italic>hsp70l:gal</italic> larvae exhibited no difference in small Ca<sup>2+</sup> fluctuations (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). Subsequent quantification of galanin levels in the brain through qPCR unveiled a 1.8-fold increase in galanin transcripts (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) in <italic>hsp70l:gal</italic> larvae compared to their wild-type siblings, potentially explaining the more subtle effects observed on brain activity. To further examine the role of galanin in regulating whole brain activity, we used <italic>galanin<sup>t12ae/t12ae</sup></italic> mutants (<italic>gal<sup>-/-</sup></italic> mutants) that carry a 7 bp deletion in exon 3 of the <italic>galanin</italic> gene which leads to a premature stop codon (<xref ref-type="bibr" rid="bib15">Eskova et al., 2020</xref>). The absence of galanin protein was confirmed in an antibody staining showing a characteristic half-ring of galanin-positive fibers in the diencephalon that was completely absent in <italic>gal<sup>-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). While other studies focused their analysis in <italic>gal<sup>-/-</sup></italic> mutants on their locomotion (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>; <xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>) and sleep (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>), we want to assess the effects of a galanin deficiency on the brain. When performing Ca<sup>2+</sup> imaging, we found that brain activity is heavily increased in <italic>gal<sup>-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2G</xref>) compared to wild-type larvae. While overexpression of galanin primarily influences larger Ca<sup>2+</sup> events, the absence of galanin specifically affects smaller Ca<sup>2+</sup> fluctuations. The increased frequency of these events is accompanied by a decrease in both amplitude and duration (<xref ref-type="fig" rid="fig2">Figure 2I–K</xref>). To delve deeper into the galanin system, we took a targeted approach focusing on a specific galanin receptor in zebrafish. Zebrafish have four galanin receptors: <italic>galr1a</italic>, <italic>galr1b</italic>, <italic>galr2a</italic>, and <italic>galr2b</italic>. While information about these receptors in zebrafish is limited, studies indicate that <italic>galr1a</italic> is widely expressed in the brain, and sequence identity closely resemble those of mammalian GALR1 (<xref ref-type="bibr" rid="bib15">Eskova et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Kim et al., 2014</xref>). To investigate the actions of <italic>galr1a</italic> in zebrafish, we conducted F0 knockouts which enable a direct analysis of the injected embryos, bypassing the need to establish stable lines (<xref ref-type="bibr" rid="bib34">Kroll et al., 2021</xref>). We found that <italic>galr1a</italic> crispants have an increased number of small Ca<sup>2+</sup> events in the brain, compared to control-injected larvae (<xref ref-type="fig" rid="fig2">Figure 2O</xref>). The absence of <italic>galr1a</italic> specifically affects the frequency of smaller Ca<sup>2+</sup> fluctuations, similar to <italic>gal<sup>-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2I</xref>), suggesting that galanin might regulate whole-brain activity via <italic>galr1a</italic>. We could not detect an upregulation of galanin in <italic>galr1a</italic> crispants, ruling out genetic compensation effects (<xref ref-type="fig" rid="fig2">Figure 2N</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>gal</italic> controls whole-brain activity.</title><p>(<bold>A</bold>) Representative calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf control (blue, top) and <italic>hsp70l:gal</italic> sibling (orange, bottom). (<bold>B</bold>) Area under the curve (AUC) calculated over 1 hr recording, normalized to control (n control = 25; n <italic>hsp70l:gal</italic> = 29). (<bold>C</bold>) Galanin transcript levels in pools of control vs. <italic>hsp70l:gal</italic> brains (n = 3). (<bold>D</bold>) Number of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right). (<bold>E</bold>) Average amplitude of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>F</bold>) Average duration of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>G</bold>) Representative calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf control (blue, top) and <italic>gal<sup>-/-</sup></italic> larva (yellow, bottom). (<bold>H</bold>) AUC calculated over 1 hr recording, normalized to control (n control = 24; n <italic>gal<sup>-/-</sup></italic> = 24). (<bold>I</bold>) Number of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right). (<bold>J</bold>) Average amplitude of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>K</bold>) Average duration of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>L</bold>) Representative calcium signals (<italic>elavl3:GCaMP6f</italic>) recorded across the brain of 5 dpf control injected (blue, top) and <italic>galr1a</italic> crispants (galr1aKO) larva (green, bottom). (<bold>M</bold>) AUC calculated over 1 hr recording, normalized to control (n control = 28; n <italic>galr1a</italic> crispants = 23). (<bold>N</bold>) Galanin transcript levels in pools of control vs. galr1aKO brains (n = 3). (<bold>O</bold>) Number of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right). (<bold>P</bold>) Average amplitude of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. (<bold>Q</bold>) Average duration of Ca<sup>2+</sup> events above 5% ΔF/F<sub>0</sub> (left) and 10% ΔF/F<sub>0</sub> (right) per larva. Significance levels: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05, ns = not significant (p&gt;0.05), Wilcoxon-Mann-Whitney test (<bold>B, E, F, H, J, K, M, O, P</bold>), negative binomial regression (<bold>D</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98634-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Heat shock decreases brain activity of 5 dpf wild-type larvae.</title><p>(<bold>A</bold>) Representative calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf unexposed wild-type larva (blue, top) and 5 dpf wild-type larvae with a 37 °C heat shock for either 10 min (steelblue blue, middle) or 30 min (light blue, bottom) with different recovery times at room temperature. Significance levels: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05, ns = not significant (p&gt;0.05), Wilcoxon-Mann-Whitney test (<bold>C, D</bold>), negative binomial regression (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98634-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Immunostaining confirms protein deficiency in <italic>gal <sup>-/-</sup></italic> mutants whole-mount immunostaining of galanin localized in the diencephalon of 5 dpf zebrafish larvae.</title><p>Antibodies used for staining included anti-galanin (green) and anti-ac. tubulin (acetylated tubulin, magenta). (<bold>A1</bold>) representative galanin staining in control larvae. (<bold>A2, A3</bold>) Single immunohistochemical channels. (<bold>B1</bold>) representative galanin staining in <italic>gal <sup>-/-</sup></italic> larvae. (<bold>B2, B3</bold>) Single immunohistochemical channels. Scale bar = 25 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98634-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Taken together, we could show that galanin is crucial in controlling spontaneous brain activity, and that this is at least partially regulated by <italic>galr1a</italic>.</p></sec><sec id="s2-3"><title><italic>gal</italic> exerts only a modest effect on seizure activity in <italic>eaat2a</italic> mutants</title><p>While we could show that galanin has direct implications in regulating whole brain activity, others have investigated its antiepileptic properties. It was shown that galanin signaling can affect the seizure thresholds and severity in mice (<xref ref-type="bibr" rid="bib17">Fetissov et al., 2003</xref>; <xref ref-type="bibr" rid="bib25">Jacoby et al., 2002</xref>; <xref ref-type="bibr" rid="bib50">Mazarati et al., 2000</xref>; <xref ref-type="bibr" rid="bib12">Drexel et al., 2018</xref>), and can reduce the occurrence of seizure-like behavioral episodes and their intensity in zebrafish (<xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>). The increased levels of galanin observed in <italic>eaat2a<sup>-/-</sup></italic> mutants could be interpreted as an internal compensatory mechanism, possibly serving to shield neurons from excitotoxicity. The observed interictal hypoactivity may be a consequence of the brain’s deliberate neuroprotective strategy so toduce the occurrence of seizures. To investigate if galanin could indeed act as a neuroprotective agent we, examined if additional galanin leads to seizure protection in <italic>eaat2a<sup>-/-</sup></italic> mutants. <italic>eaat2a<sup>-/-</sup></italic> mutants exhibit global spontaneous seizures lasting all the way up to over 6 min in duration (<xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>). Although not all <italic>eaat2a<sup>-/-</sup></italic> mutants exhibit spontaneous epileptic seizures in the 1 hr recording window, an estimated 57.14–60.00% (12/21; 21/35) of larvae do (<xref ref-type="fig" rid="fig3">Figure 3</xref>). We then compared seizures of 5 dpf <italic>eaat2a<sup>-/-</sup>;hsp70l:gal</italic> with <italic>eaat2a<sup>-/-</sup></italic> larvae and found no significant difference in seizure susceptibility or severity in spontaneous epileptic seizures. Neither the number of seizures, their amplitude, duration nor time to peak was altered (<xref ref-type="fig" rid="fig3">Figure 3A–F</xref>). This is, however, not surprising, as we showed earlier that 5 dpf <italic>eaat2a<sup>-/-</sup></italic> mutants already overexpress galanin by 15.4-fold (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and, therefore, more galanin might not make a big difference. To investigate if galanin is still important in seizure protection, we turned to analyze <italic>eaat2a<sup>-/-</sup>;gal<sup>-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3G-L</xref>). We found that area under the curve (AUC) of seizures is slightly increased (<xref ref-type="fig" rid="fig3">Figure 3I</xref>) and seizure amplitudes are increased compared to <italic>eaat2a<sup>-/-</sup></italic> controls (<xref ref-type="fig" rid="fig3">Figure 3K</xref>). Neither the number of seizures, the seizure duration nor the time to peak changed significantly (<xref ref-type="fig" rid="fig3">Figure 3H, J and L</xref>). Taken together, galanin demonstrates only a modest level of seizure protection in <italic>eaat2a<sup>-/-</sup></italic> mutants.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>gal</italic> Exerts a modest effect on seizure activity in <italic>eaat2a</italic><sup>-/-</sup> mutants.</title><p>(<bold>A</bold>) Averaged calcium signals (<italic>elavl3:GCaMP5G</italic>) for spontaneous seizures recorded across the brain of 5 dpf control (<italic>eaat2a<sup>-/-</sup></italic>) larva (blue, 35 events) and <italic>eaat2a<sup>-/-</sup>;hsp70l:gal</italic> (orange, 39 events) aligned by 50% of maximum amplitude. Shaded area represents SEM. (<bold>B</bold>) Time to peak calculated from beginning of aligned seizure until maximum ΔF/F<sub>0</sub> signal. (<bold>C</bold>) Area under the curve (AUC) calculated over spontaneous seizures normalized to control (n control = 35; n <italic>eaat2a<sup>-/-</sup>;hsp70l:gal</italic> = 39). (<bold>D</bold>) Number of spontaneous seizures per larva. (<bold>E</bold>) Amplitude of spontaneous seizures per larva. (<bold>F</bold>) Duration of spontaneous seizures per larva. (<bold>G</bold>) Averaged calcium signals (<italic>elavl3:GCaMP5G</italic>) for spontaneous seizures recorded across the brain of 5 dpf control (<italic>eaat2a<sup>-/-</sup></italic>) larva (blue, 77 events) and <italic>eaat2a<sup>-/-</sup>;gal<sup>-/-</sup></italic> (yellow, 89 events) aligned by 50% of maximum amplitude. Shaded area represents SEM. (<bold>H</bold>) Time to peak calculated from beginning of aligned seizure until maximum ΔF/F<sub>0</sub> signal. (<bold>I</bold>) AUC calculated over spontaneous seizures normalized to control (n control = 77; n <italic>eaat2a<sup>-/-</sup>;gal<sup>-/-</sup></italic> = 89). (<bold>J</bold>) Number of spontaneous seizures per larva. (<bold>K</bold>) Amplitude of spontaneous seizures per larva. (<bold>L</bold>) Duration of spontaneous seizures per larva. Significance levels: ***p&lt;0.001, **p&lt;0.01, *p&lt; 005, ns = not significant (p&gt;0.05), Wilcoxon-Mann-Whitney test (<bold>B, C, E, F, H, I, K, L</bold>), negative binomial regression (<bold>D, J</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98634-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title><italic>gal</italic> promotes seizures in PTZ-exposed larvae</title><p>To investigate if galanin could mediate epileptic seizures in another state-of-the-art seizure model, we turned again to the GABA<sub>A</sub> receptor antagonist, PTZ. We applied 20 mM PTZ to the larvae directly before Ca<sup>2+</sup> imaging and compared PTZ-exposed larvae with their unexposed siblings. PTZ exposure increases neuronal activity in a progressive manner and triggers short epileptic seizures lasting up to 2 min in duration (<xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>; <xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>gal promotes seizures in pentylenetetrazole (PTZ) exposed larvae.</title><p>(<bold>A</bold>) Averaged calcium signals (<italic>elavl3:GCaMP6f</italic>) for seizures elicited by 20 mM PTZ recorded across the brain of 5 dpf control (blue, 76 events) and <italic>hsp70l:gal</italic> (orange, 113 events) aligned by 50% of maximum amplitude. Shaded area represents SEM. (<bold>B</bold>) Time to peak calculated from beginning of aligned seizure until maximum ΔF/F<sub>0</sub> signal. (<bold>C</bold>) Area under the curve (AUC) calculated over seizures normalized to control (n control = 76; n <italic>hsp70l:gal</italic> = 113). (<bold>D</bold>) Number of seizures per larva. (<bold>E</bold>) Amplitude of seizures per larva. (<bold>F</bold>) Duration of seizures per larva. (<bold>G</bold>) Averaged calcium signals (<italic>elavl3:GCaMP6f</italic>) for seizures elicited by 20 mM PTZ recorded across the brain of 5 dpf control (blue, 29 events) and <italic>gal<sup>-/-</sup></italic> (yellow, 10 events) aligned by 50% of maximum amplitude. Shaded area represents SEM. (<bold>H</bold>) Time to peak calculated from beginning of aligned seizure until maximum ΔF/F<sub>0</sub> signal. (<bold>I</bold>) AUC calculated over seizures normalized to control (n control = 29; n <italic>gal<sup>-/-</sup></italic> = 10). (<bold>J</bold>) Number of seizures per larva. (<bold>K</bold>) Amplitude of seizures per larva. (<bold>L</bold>) Duration of seizures per larva. (<bold>M</bold>) Averaged calcium signals (<italic>elavl3:GCaMP6f</italic>) for seizures elicited by 20 mM PTZ recorded across the brain of 5 dpf control injected (blue, seven events) and <italic>galr1a</italic> crispants (galr1aKO, green, 14 events) aligned by 50% of maximum amplitude. Shaded area represents SEM. (<bold>N</bold>) Time to peak calculated from beginning of aligned seizure until maximum ΔF/F<sub>0</sub> signal. (<bold>O</bold>) AUC calculated over seizures normalized to control (n control = 7; n <italic>galr1a</italic> crispants = 14). (<bold>P</bold>) Number of seizures per larva. (<bold>Q</bold>) Amplitude of seizures per larva. (<bold>R</bold>) Duration of seizures per larva. Significance levels: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05, ns = not significant (p&gt;0.05), Wilcoxon-MannWhitnMann Whitney (<bold>B, C, E, F, H, I, K, L, N, O, Q, R</bold>), negative binomial regression (<bold>D, J, P</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98634-fig4-v1.tif"/></fig><p>Despite the observed decrease in neuronal activity resulting from galanin overexpression (<xref ref-type="fig" rid="fig2">Figure 2A, D and E</xref>), exposing 5 dpf <italic>hsp70l:gal</italic> larvae to 20 mM PTZ surprisingly led to a significant increase in seizure activity (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) compared to non-exposed wild-type siblings. While the seizure number increases significantly (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), there is also a decrease in seizure duration (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Conversely, the absence of galanin during acute PTZ exposure induces an opposing phenotype (<xref ref-type="fig" rid="fig4">Figure 4J-K</xref>). A marked decrease in the occurrence of epileptic seizures is evident in <italic>gal<sup>-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4K</xref>) compared to wild-type larvae. Merely 6 out of 38 <italic>gal<sup>-/-</sup></italic> mutants (15.8%) display seizures, whereas 20 out of 39 wild-type larvae (51.3%) exhibit seizure activity. However, when <italic>gal<sup>-/-</sup></italic> larvae experience seizures upon PTZ, the seizure amplitude is significantly reduced (<xref ref-type="fig" rid="fig4">Figure 4K</xref>), while their duration (<xref ref-type="fig" rid="fig4">Figure 4L</xref>) increases. Furthermore, time to peak and AUC of seizures are increased (<xref ref-type="fig" rid="fig4">Figure 4H–I</xref>). Strikingly, while seizures in <italic>eaat2a<sup>-/-</sup></italic> control larvae come to an abrupt stop after a gradual decline, seizures seem to taper off over the duration of several minutes in <italic>gal<sup>-/-</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4G</xref>).</p><p>Contrary to our initial expectations derived from prior results indicating a potentially sedative and neuroprotective role of galanin, the exposure of larvae to PTZ under acute conditions resulted in an opposing observation. While it was surprising that galanin seems to increase seizure susceptibility instead of protecting the larvae from seizures, this fits very well with results from a recent publication, where the authors found galanin to be involved in a stress response upon salient stimuli (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). The authors hypothesize that galanin binds to autoreceptors on Gal<sup>+</sup> neurons, reducing their own activity and, therefore, reducing their secretion of galanin and additionally reduce release of GABA on downstream stress-promoting neurons, ultimately leading to an increase in stress (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). While the specific galanin receptor governing the stress pathway remains elusive, it has been found that GALR1 exerts an inhibitory influence on neuronal activity in mammals, while GALR2 displays a dual role, exhibiting both inhibitory and excitatory effects (<xref ref-type="bibr" rid="bib38">Lang et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Ma et al., 2001</xref>). Notably, it has been demonstrated that a significant portion of Gal+ neurons in the preoptic area in zebrafish express either <italic>galr1a</italic>, <italic>galr1b,</italic> or <italic>galr2b</italic> (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). To discern whether <italic>galr1a</italic>, beyond its role in regulating whole-brain activity, is intricately linked to the stress response pathway, we implemented F0 knockouts of <italic>galr1a</italic> and exposed injected larvae to PTZ-induced stress. If <italic>galr1a</italic> were the autoreceptor on GABAergic Gal+ neurons, we would expect a decrease in seizure number similar to <italic>gal<sup>-/-</sup></italic> mutants. However, our examination of <italic>galr1a</italic> crispants exposed to 20 mM PTZ revealed no significant decrease in seizure frequency compared to control injected larvae (<xref ref-type="fig" rid="fig4">Figure 4P</xref>). This suggests that <italic>galr1a</italic> is not the hypothesized autoreceptor governing this stress response pathway. Furthermore, our findings reveal that <italic>galr1a</italic> crispants manifest a more severe response to PTZ-induced seizures, evident in the substantial increase in both amplitude and duration compared to control injected larvae (<xref ref-type="fig" rid="fig4">Figure 4Q and R</xref>). Strikingly, several seizure characteristics in <italic>galr1a</italic> crispants mirror those observed in <italic>gal<sup>-/-</sup></italic> mutants exposed to PTZ. Specifically, AUC of seizures shows a marked increase, the time to peak extends, and seizures exhibit a gradual tapering off over several minutes, a distinct pattern in contrast to the rapid resolution seen in controls (<xref ref-type="fig" rid="fig4">Figure 4M–O</xref>).</p><p>Taken together, our findings underscore the multifaceted role of galanin, not only in inducing a sedating effect on the entire brain but also in playing a pivotal role in a recently described stress response pathway (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). Although the specific receptor orchestrating this stress pathway remains unidentified, our research decisively eliminates <italic>galr1a</italic> as the regulator. Collectively, this leads us to the conclusion that galanin likely exerts its sedative actions during epileptic seizures through <italic>galr1a</italic>, and that the stress response pathway is governed by another galanin receptor.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Sustaining brain homeostasis enables consistent behavior and demands the brain’s ongoing integration of sensory information from the environment, internal behavioral state of the organism, and the elaborate networks of synaptic and non-synaptic connectivity (<xref ref-type="bibr" rid="bib44">Lin et al., 2022</xref>). While maintenance of homeostasis requires multiple factors, here we focused on the neuropeptide galanin, as it has been shown to impact whole organism activity (<xref ref-type="bibr" rid="bib71">Woods et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>, sleep <xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Gaus et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Kroeger et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">McGinty and Szymusiak, 2003</xref>; <xref ref-type="bibr" rid="bib47">Ma et al., 2019</xref>), and responses to stress (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Khoshbouei et al., 2002</xref>; <xref ref-type="bibr" rid="bib56">Picciotto et al., 2010</xref>; <xref ref-type="bibr" rid="bib68">Tillage et al., 2021</xref>; <xref ref-type="bibr" rid="bib67">Tillage et al., 2020</xref>). In animals such as zebrafish, sleep is operationally defined as periods of locomotor quiescence with an increased arousal threshold (<xref ref-type="bibr" rid="bib8">Barlow and Rihel, 2017</xref>; <xref ref-type="bibr" rid="bib21">Hendricks et al., 2000</xref>; <xref ref-type="bibr" rid="bib61">Raizen et al., 2008</xref>; <xref ref-type="bibr" rid="bib69">van Alphen et al., 2013</xref>). A recent study showed evidence for galanin being important in homeostatic sleep regulation in zebrafish (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>). Others found a decrease in locomotor activity upon galanin overexpression (<xref ref-type="bibr" rid="bib71">Woods et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Podlasz et al., 2018</xref>). We similarly found that overexpression of galanin leads to a reduction in brain activity, while lack of galanin leads to neuronal hyperactivity. Interestingly, most sleep-active GABAergic neurons in the ventrolateral preoptic area (VLPO) are galanin positive in mammals and the VLPO has long been proposed to be a major sleep regulator (<xref ref-type="bibr" rid="bib33">Kroeger et al., 2018</xref>; <xref ref-type="bibr" rid="bib18">Gaus et al., 2002</xref>; <xref ref-type="bibr" rid="bib45">Lu et al., 2000</xref>). While our investigation did not delve into galanin’s direct influence on sleep, our results suggest that galanin exerts a sedative influence on the brain. This calming effect is likely governed by <italic>galr1a</italic>, as lack of <italic>galr1a</italic> leads to similar neuronal hyperactivity of the brain as the absence of galanin. This is in line with the observation that GALR1 activation inhibits the expressing cell by opening G protein-regulated inwardly rectifying K<sup>+</sup> channels (GIRKs) (<xref ref-type="bibr" rid="bib38">Lang et al., 2015</xref>). Moreover, it has been shown that galanin signaling is implicated in the reduction of glutamate release (<xref ref-type="bibr" rid="bib31">Kokaia et al., 2001</xref>; <xref ref-type="bibr" rid="bib13">Elliott-Hunt et al., 2004</xref>; <xref ref-type="bibr" rid="bib73">Zini et al., 1993</xref>), which could further explain its calming effect on the brain.</p><p>Besides galanin regulating global neuronal activity, we showed that excessive neuronal activity is a potential predictor of subsequent reduced neuronal inactivity similar to another study (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>). Employing two distinct models characterized by increased neuronal activity and epileptic seizures, our findings elucidate a consistent pattern – elevated galanin levels and decline of overall neuronal activity. This discovery is particularly interesting, considering that post-ictal fatigue is a common symptom in epilepsy patients (<xref ref-type="bibr" rid="bib20">Hamelin et al., 2010</xref>; <xref ref-type="bibr" rid="bib16">Ettinger et al., 1999</xref>) and it further mimics slow background brain activity and reduced muscle tone present in human patients (<xref ref-type="bibr" rid="bib3">Allen et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Epi4K Consortium, 2016</xref>; <xref ref-type="bibr" rid="bib19">Guella et al., 2017</xref>). Moreover, the reduced neuronal activity is particularly intriguing, especially when considering the divergent mechanisms of action utilized by the two models we employed. In <italic>eaat2a<sup>-/-</sup></italic> mutants glutamate uptake into astroglia is deprecated. This results in an accumulation of glutamate in the synaptic cleft, leading to the initiation of severe epileptic seizures that spread across the entire brain (<xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>). PTZ, on the other hand, acts as a GABA<sub>A</sub> receptor antagonist, leading to the disinhibition of the brain and a subsequent dose-dependent increase in neuronal activity, ultimately triggering epileptic seizures. The observation that both models show a ruced neuronal activity interictally (<italic>eaat2a<sup>-/-</sup></italic>) or after washout (PTZ), which coincides with upregulation of galanin, suggests possible implications of galanin in various types of epileptic seizures. Galanin has been shown to be antiepileptic in numerous studies (<xref ref-type="bibr" rid="bib51">McColl et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Fetissov et al., 2003</xref>; <xref ref-type="bibr" rid="bib25">Jacoby et al., 2002</xref>; <xref ref-type="bibr" rid="bib50">Mazarati et al., 2000</xref>; <xref ref-type="bibr" rid="bib31">Kokaia et al., 2001</xref>). It should also be noted that Galanin is known to be depleted by seizures in the hippocampus of mice (<xref ref-type="bibr" rid="bib49">Mazarati et al., 1998</xref>). In an attempt to assess potential antiepileptic effects of galanin in zebrafish, we manipulated galanin levels in <italic>eaat2a<sup>-/-</sup></italic> mutants. However, the impact of galanin on seizures in <italic>eaat2a<sup>-/-</sup></italic> larvae was found to be minimal, likely attributed to the exceptionally severe seizure phenotype associated with <italic>eaat2a</italic> dysfunction (<xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>). In acute PTZ exposure, however, galanin modulated seizures significantly. While we hypothesized to see antiepileptic effects upon modulation of galanin, our observations did not initially support this expectation. Galanin overexpression significantly elevated the number of seizures, whereas the absence of galanin led to a decrease in seizure occurrence. This is, however, in line with results from a recent publication, where galanin was found to be involved in fine-tuning a stress response upon exposure to hypertonic solution (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). Supposedly, galanin binds to autoreceptors on Gal<sup>+</sup> neurons, reducing their own activity and, therefore, reducing their release of GABA on downstream stress-promoting neurons, ultimately leading to an increase in stress via Crh<sup>+</sup> neurons (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). This can be thought of as a control system to fine-tune neuroendocrine and behavioral responses to stressful situations. While it is not clear which galanin receptor is governing this inhibitory loop, <italic>galr1a</italic> stands out as the most expressed and main inhibitory galanin receptor in the zebrafish brain (<xref ref-type="bibr" rid="bib15">Eskova et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Kim et al., 2014</xref>). Hence, we explored whether <italic>galr1a</italic> crispants exhibit a reduction in seizure occurrence similar to <italic>gal<sup>-/-</sup></italic> mutants upon PTZ-induced stress. Surprisingly, we found that seizures did not decrease in number in <italic>galr1a</italic> crispants, indicating that <italic>galr1a</italic> might not function as the autoreceptor on GABAergic Gal<sup>+</sup> neurons. Furthermore, seizures got more severe in <italic>galr1a</italic> crispants, as their amplitude and duration increased significantly, similar as in <italic>gal<sup>-/-</sup></italic> mutants. This suggests that galanin influences whole brain activity in at least two ways during epileptic seizures. On one hand, galanin acts as a sedating agent, decreasing seizure severity, which is likely governed by <italic>galr1a</italic>. On the other hand, galanin increases seizure occurrence, similar to increasing stress in another study (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>) and we hypothesize that this might be dependent on one of the other galanin receptors.</p><p>Taken together, our data sheds light on a multifaceted role of galanin in regulating whole brain activity. The complexity of galanin’s effects is evident in our study, where it can serve as a central nervous system depressant or regulate stress response pathways. This is particularly the case during acute stress, where its modulatory role overrides its sedative actions. This suggests a nuanced interplay between galanin and various physiological processes, elucidating on its potential significance in modulating stress-related pathways. Exploring the mechanisms underlying these effects could offer valuable insights into the intricate role of galanin and its implications for various physiological functions or neurological disorders such as epilepsy. Other studies have revealed that galanin-producing neurons in the hypothalamus are involved in regulating diverse processes including food intake (<xref ref-type="bibr" rid="bib65">Schick et al., 1993</xref>; <xref ref-type="bibr" rid="bib1">Adams et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Qualls-Creekmore et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Laque et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Leibowitz et al., 1998</xref>), parental behavior (<xref ref-type="bibr" rid="bib30">Kohl et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Wu et al., 2014</xref>), sleep (<xref ref-type="bibr" rid="bib63">Reichert et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Gaus et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Kroeger et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">McGinty and Szymusiak, 2003</xref>; <xref ref-type="bibr" rid="bib47">Ma et al., 2019</xref>), and stress (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Juhasz et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Hökfelt et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Khoshbouei et al., 2002</xref>; <xref ref-type="bibr" rid="bib56">Picciotto et al., 2010</xref>). Moreover, discrete subsets of hypothalamic neurons express galanin, with each subset displaying distinct responses to various stimuli. This diversity in neuronal responsiveness may account for the broad spectrum of physiological functions governed by galanin within the brain (<xref ref-type="bibr" rid="bib10">Corradi et al., 2022</xref>). Investigating the function of these galaninergic neuron populations represents a crucial next step in unraveling how galanin modulates neuronal activity and ultimately influences brain function. Although many questions remain, our data reveals a multifaceted role of galanin, where galanin regulates whole-brain activity but also shapes acute responses to stress and epileptic seizures.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Zebrafish lines and maintenance</title><p>All zebrafish experiments were performed on larvae at 5 d post fertilization (dpf). Zebrafish were kept under standard conditions at 28 °C on a 14 hr/10 hr light/dark cycle (<xref ref-type="bibr" rid="bib53">Mullins et al., 1994</xref>). For experiments, adult animals were set up pairwise, and embryos and larvae were raised in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4). All experiments were conducted in accordance with local authorities (Zürich, Kantonales Veterinäramt TV4206). The study’s developmental stages preclude the determination of zebrafish sex. Animals were randomly allocated to experimental groups.</p><p>The following previously established transgenic lines were used in this study and combined according to needs:</p><list list-type="simple" id="list1"><list-item><p><italic>Tg(elavl3:GCaMP5G)</italic> <xref ref-type="bibr" rid="bib2">Akerboom et al., 2012</xref>; <italic>Tg(elavl3:GCaMP6f)</italic> <xref ref-type="bibr" rid="bib9">Chen et al., 2013</xref>; <italic>Tg(hsp70l:gal)<sup>a135</sup></italic>  <xref ref-type="bibr" rid="bib71">Woods et al., 2014</xref>; <italic>eaat2a<sup>zh7</sup></italic> (<xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref>); <italic>gal<sup>t12ae 41</sup></italic></p></list-item></list><p>Unless otherwise stated, experiments were performed with <italic>nacre<sup>-/-</sup></italic> (Ca<sup>2+</sup> imaging and qPCR) and AB strain (qPCR) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:ZIRC_ZL1">ZIRC_ZL1</ext-link>) zebrafish.</p></sec><sec id="s4-2"><title>Genotyping</title><p>Larvae were genotyped after each experiment for <italic>hsp70l:gal</italic>, <italic>eaat2a</italic>, and <italic>galr1a</italic>. For experiments with <italic>gal<sup>t12ae/t12ae</sup></italic> mutants, adults were genotyped, kept in homozygosity, and subsequently incrossed for experiments. For genotyping, whole larvae were anesthetized on ice, lysed in base solution (25 mM NaOH, 0.2 mM EDTA), and neutralized in neutralization solution (40 mM Tris-HCl), before PCR was performed. The target site for <italic>hsp70l:gal</italic> (primers: 5’-<named-content content-type="sequence">CTTGTTGACTAGAAAAATCCTTTCA</named-content>-3’ and 5’-<named-content content-type="sequence">TCTCTCTTTCCTGCCAGTCC</named-content>-3’), <italic>eaat2a</italic> (primers: 5’-<named-content content-type="sequence">GATGCAGTCGTATGGGAA</named-content>-3’ and 5’-<named-content content-type="sequence">CCTTCTCCCAGATTCTCC</named-content>-3’), and <italic>galr1a</italic> (primers: 5’-<named-content content-type="sequence">ATGGGCACCCAAAACAACAGT</named-content>-3’ and 5’-<named-content content-type="sequence">GCGGCAGCACATATCCAAAAA</named-content>-3’) was PCR amplified with a fast-cycling polymerase (KAPA2G Fast HotStart PCR kit, KAPA Biosystems) and a subsequent gel-electrophoresis, to allow detection of the mutant fragments.</p></sec><sec id="s4-3"><title>Quantitative real-time PCR (qPCR)</title><p>5 dpf larvae were anesthetized on ice and brains dissected using an insect pin and a syringe needle in a dish containing RNA later (Sigma-Aldrich). To confirm genotype, remaining tissue was lysed and gDNA amplified by means of PCR (KAPA Biosystems) as described above. Total RNA of equal pools of (n=15) larval brains was extracted using the RNeasy kit (Qiagen). RNA was reverse transcribed to cDNA using the Super Script III First-strand synthesis system (Invitrogen). The qPCR reactions were performed using SsoAdvanced Universal SYBR Green Supermix on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad). <italic>actb1</italic>, <italic>tbp</italic> and <italic>rpl13a</italic> were chosen as reference genes. Primer efficiencies for <italic>gal</italic> (5’-<named-content content-type="sequence">TGAGGATGTCGTCCATACCATC</named-content>-3’ and 5’-<named-content content-type="sequence">GGTTGACTGATCTCTTCTGATGTG</named-content>-3’), <italic>actb1</italic> (5'-<named-content content-type="sequence">CAGACATCAGGGAGTGATGGTTGG</named-content>-3' and 5’-<named-content content-type="sequence">CAGATCTTCTCCATGTCATCCCAG</named-content>-3'), <italic>tbp</italic> (5’-<named-content content-type="sequence">ACAACAGCCTACCTCCTTTCG</named-content>-3’ and 5’-<named-content content-type="sequence">CGTCCCATACGGCATCATAGG</named-content>-3’) and <italic>rpl13a</italic> (5’-<named-content content-type="sequence">TCTGGAGGACTGTAAGAGGTATGC</named-content>-3’ and 5’-<named-content content-type="sequence">AGACGCACAATCTTGAGAGCAG</named-content>-3’ <xref ref-type="bibr" rid="bib43">Lin et al., 2009</xref>) were calculated by carrying out a dilution series and specificity was determined using melting curve analysis. After primer efficiencies were determined equal, brain samples were used for qPCR using 1 ng of cDNA per reaction. The controls ‘no reverse transcription control’ (nRT control) and ‘no template control’ (NTC) were performed with every qPCR reaction. All reactions were performed in technical triplicates. Data was analyzed in CFX Maestro Software from Bio-Rad and GraphPad Prism version 10.1.2 for Windows, GraphPad Software, Boston, Massachusetts USA, <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>. Expression of <italic>gal</italic> was normalized to expression of <italic>actb1</italic>, <italic>tbp,</italic> and <italic>rpl13a</italic>. Relative expression levels were calculated using the ΔΔCt method. Each experiment was performed in three biological replicates.</p></sec><sec id="s4-4"><title>F0 knockouts</title><p>We performed F0 knockouts similar as described in <xref ref-type="bibr" rid="bib34">Kroll et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Kroll and Rihel, 2021</xref>; <xref ref-type="bibr" rid="bib36">Kroll, 2022</xref>. In brief, three CRISPR target sites for <italic>galr1a</italic> (<italic>ENSDARG00000005522</italic>) were selected with CHOPCHOP <xref ref-type="bibr" rid="bib37">Labun et al., 2019</xref>. While it was not possible to generate efficient guides targeting 3 different exons, we chose to generate 3 guide RNAs #1 (5’-<named-content content-type="sequence">CGCCTACTATCAGGGCATCGTGG</named-content>-3’), #2 (5’-<named-content content-type="sequence">TGGCGTCCTTGGAAACTCTCTGG</named-content>-3’), #3 (5’-<named-content content-type="sequence">GGTGAAGATGCTTACGAGCATGG</named-content>-3’) targeting the same exon (exon 1). Reagents were ordered from integrated DNA technologies (IDT) and were resuspended, annealed, and pooled according to <xref ref-type="bibr" rid="bib35">Kroll and Rihel, 2021</xref>. For generating the F0 knockouts, one-cell staged embryos were injected with 1 nl injection mix (10.1 fmol [357 pg] per gRNA) into the yolk. Control injection mix contained a set of three scrambled RNPs, which carry gRNAs IDT, Alt-R CRISPR-Cas9 Negative Control crRNA #1 (#1072544), #2 (#1072545), #3 (#1072546) (<xref ref-type="bibr" rid="bib34">Kroll et al., 2021</xref>) with pseudo-random sequences predicted to not match any genomic locus. For all experiments, scramble RNP-injected siblings were used as controls. As stable <italic>galr1a</italic> mutants (<xref ref-type="bibr" rid="bib15">Eskova et al., 2020</xref>) lack overt morphological phenotypes apart from their pigmentation phenotype, all larvae with abnormal appearance were discarded to rule out injection artifacts.</p></sec><sec id="s4-5"><title>Calcium imaging and data analysis</title><p>5 dpf larvae in the Tg(<italic>elavl3:GCaMP5G</italic>) or Tg(<italic>elavl3:GCaMP6f</italic>) background, respectively, were individually immobilized in a drop of 2% low melting temperature agarose (Sigma-Aldrich) in a small cell culture dish. Agarose was left to dry briefly before a part was cut away and a second larvae was embedded close to the first larvae and in the same focal plane. Dish was filled with E3 medium. Calcium signals were recorded using an Olympus BX51 WI epifluorescence microscope with a 5 x objective and by means of a camera (1.33 Hz sampling rate) for 1 hr with the VisiView software established by the Visitron Systems GmbH. In each experiment, the GCaMP fluorescence signal of manually selected regions of interest (ROIs, whole brain) was extracted using Fiji ImageJ (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_003070">SCR_003070</ext-link>) (<xref ref-type="bibr" rid="bib66">Schindelin et al., 2012</xref>). Images were corrected for sample drift with Correct_3D_Drift.py script (<xref ref-type="bibr" rid="bib55">Parslow et al., 2014</xref>) in Fiji ImageJ (<xref ref-type="bibr" rid="bib66">Schindelin et al., 2012</xref>). For each time point, the mean intensity of each ROI was measured and further processed using a custom script in R with the RStudio interface <xref ref-type="bibr" rid="bib62">R Development Core Team, 2022</xref>; <xref ref-type="bibr" rid="bib58">Posit team, 2023</xref>. The baseline (F<sub>0</sub>) as 1% of the total fluorescence of every ROI was computed within a moving window of 150 s (for normal brain activity) or 300 s (for <italic>eaat2a</italic><sup>-/-</sup> seizure analysis) per fish. Subsequently, the fractional change in fluorescence (ΔF/F<sub>0</sub>) of each ROI was determined. In all imaging experiments, hear thetbeat of larvae was assessed before and after each experiment, and animals without heartbeat were excluded from analysis. In order to compare whole brain activity, thresholds for event detection were set. For examining normal brain activity, events were categorized into two distinct groups, 5% and 10% of ΔF/F<sub>0</sub>. Duration, amplitude, and number of events were calculated for each of these groups. For analyzing normal behavior, AUC was calculated for the whole normalized fluorescence trace except for the experiment with <italic>eaat2a</italic> mutants and the respective controls in <xref ref-type="fig" rid="fig1">Figure 1B</xref>, where AUC was calculated and averaged over two 5 min time windows per animal (same random windows for all larvae, adjusted if during seizure). To demonstrate previously published <italic>eaat2a</italic> hypoactivity <xref ref-type="bibr" rid="bib24">Hotz et al., 2022</xref> (<xref ref-type="fig" rid="fig1">Figure 1A, B, D, E and F</xref>), data from <italic>eaat2a<sup>-/-</sup></italic> (<xref ref-type="fig" rid="fig3">Figure 3A-F</xref>) and closely related wild-type larvae (<xref ref-type="fig" rid="fig2">Figure 2A-F</xref>) were re-used and differently analyzed. For this particular experiment, we removed seizures by excluding all events with amplitudes bigger than 50% ΔF/F<sub>0</sub> and a duration of more than 20 s. For all other recordings, seizures were defined as calcium fluctuations reaching at least 100% of ΔF/F<sub>0</sub> in the whole brain. Seizure duration was defined as the period from the first time point where ΔF/F<sub>0</sub> is greater than 50% (seizure initiation) until the first time point where ΔF/F<sub>0</sub> is below 50% in the brain. To generate the overlay plots (<xref ref-type="fig" rid="fig3">Figures 3A, G</xref>, <xref ref-type="fig" rid="fig4">4A, G and M</xref>); all seizures were aligned by the time point where 50% of the maximum ΔF/F<sub>0</sub> was reached. The resulting plots showcase the mean average seizure per genotype, shaded area represents the standard error of the mean (SEM). AUC and time to peak of each seizure were calculated from the beginning of the aligned seizure trace. Example Videos (<xref ref-type="video" rid="video1">Videos 1</xref>–<xref ref-type="video" rid="video8">8</xref>) are deposited in the supplements.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video1.mp4" id="video1"><label>Video 1.</label><caption><title>Whole brain activity recording in control and <italic>hsp70:gal</italic> larvae.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf control (left) and <italic>hsp70:gal</italic> (right, galanin-OE) over a 15 min time period chosen at random. The recordings were exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video2.mp4" id="video2"><label>Video 2.</label><caption><title>Whole brain activity recording in control and <italic>gal<sup>-/-</sup></italic> larvae.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf control (left) and <italic>gal<sup>-/-</sup></italic> (right, galanin-KO) over a 15 min time period chosen at random. The recordings were exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Whole brain activity recording in control and galr1aKO larvae.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) recorded across the brain of 5 dpf control (left) and galr1aKO (right) over a 15 min time period chosen at random. The recordings were exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video4.mp4" id="video4"><label>Video 4.</label><caption><title>Seizure recordings in control and <italic>hsp70:gal</italic> larvae in <italic>eaat2a <sup>-/-</sup></italic> background.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) during a typical seizure recorded across the brain of 5 dpf control (left) and <italic>hsp70:gal</italic> (right, galanin-OE) in <italic>eaat2a <sup>-/-</sup></italic> background. The seizures were captured over 150 frames (about 1 min 50 s recording) and exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video5.mp4" id="video5"><label>Video 5.</label><caption><title>Seizure recordings in control and <italic>gal<sup>-/-</sup></italic> larvae in <italic>eaat2a <sup>-/-</sup></italic> background.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) during a typical seizure recorded across the brain of 5 dpf control (left) and <italic>gal<sup>-/-</sup></italic> (right, galanin-KO) in <italic>eaat2a <sup>-/-</sup></italic> background. The seizures were captured over 150 frames (about 1 min 50 s recording) and exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video6.mp4" id="video6"><label>Video 6.</label><caption><title>Seizure recordings in control and <italic>hsp70:gal</italic> larvae acutely exposed to 20 mM PTZ.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) during a typical seizure recorded across the brain of 5 dpf control (left) and <italic>hsp70:gal</italic> (right, galanin-OE) acutely exposed to 20 mM PTZ. The seizures were captured over 125 frames (about 1 min 50 s recording) and exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video7.mp4" id="video7"><label>Video 7.</label><caption><title>Seizure recordings in control and <italic>gal<sup>-/-</sup></italic> larvae acutely exposed to 20 mM PTZ.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) during a typical seizure recorded across the brain of 5 dpf control (left) and <italic>gal<sup>-/-</sup></italic> (right, galanin-KO) acutely exposed to 20 mM PTZ. The seizures were captured over 125 frames (about 1 min 50 s recording) and exported with 7fps. Both larvae were recorded on the same day.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-98634-video8.mp4" id="video8"><label>Video 8.</label><caption><title>Seizure recordings in control and galr1aKO larvae acutely exposed to 20 mM PTZ.</title><p>Representative raw data of recorded calcium signals (<italic>elavl3:GCaMP5G</italic>) during a typical seizure recorded across the brain of 5 dpf control (left) and galr1aKO (right) acutely exposed to 20 mM PTZ. The seizures were captured over 125 frames (about 1 min 50 s recording) and exported with 7fps. Both larvae were recorded on the same day.</p></caption></media></sec><sec id="s4-6"><title>PTZ exposure</title><p>For exposure with pentylenetetrazole (PTZ), 20 mM PTZ was prepared freshly on each experimental day (Sigma-Aldrich). For acute PTZ exposure, E3 medium was replaced by 20 mM PTZ (in E3) directly before starting the 1 hr imaging period. For PTZ rebound experiments, freely swimming larvae were exposed to 20 mM PTZ (in E3) in a 50 ml cell culture dish for 1 hr, subsequently rinsed in a dish containing E3 medium, and were then transferred to a fresh dish with E3 medium for 1 hr. Larvae were embedded as described earlier and left in E3 medium until the 1 hr calcium imaging experiment was conducted precisely 2 hr after initiating the PTZ washout.</p></sec><sec id="s4-7"><title>Quantification and statistical analysis</title><p>Statistical analysis was performed using R software version 4.2.1 with the RStudio version RStudio 2023.09.1+494 interface (<xref ref-type="bibr" rid="bib62">R Development Core Team, 2022</xref>; <xref ref-type="bibr" rid="bib58">Posit team, 2023</xref>) or GraphPad Prism version 10.1.2 for Windows (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link>), GraphPad Software, Boston, Massachusetts USA, <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>. Calcium imaging data was tested for normality using the Shapiro–Wilk test. Wilcoxon-Mann-Whitney test nonpaired analysis was used for calcium imaging analysis (amplitudes, duration, AUC, time to peak). For comparing event numbers, as data was overdispersed, a negative binomial generalized linear model was fitted and assessed (package: MASS, glm.nb in R). For qPCR data, Student’s t-test in GraphPad Prism was used. Differences were considered statistically significant if p&lt;0.05. Description of the number of animals used for each experiment can be found in the figures and figure legends.</p></sec><sec id="s4-8"><title>Whole-mount immunostaining</title><p>5 dpf larvae were fixed in 4% PFA, washed in PBS, and permeabilized using acetone at –20 °C. Larvae were blocked using PBDT (PBS +1% BSA+0.5% Triton X-100 +1% DMSO) with 10% goat serum for 30 min at room temperature and subsequently incubated with primary antibodies overnight at 4 °C. Rabbit anti-galanin (1:400, EDM Milipore AB5909), Mouse anti-acetylated tubulin (IgG2b, 1:500, Sigma 7451) were used as primary antibodies. Following PBDT washes, embryos were incubated in secondary antibodies Goat anti-Rabbit Alexa Fluor 488 (Invitrogen A-11008, Thermo Fisher Scientific) and goat anti-mouse IgG2b Alexa Fluor 647 (Invitrogen A-21242, Thermo Fisher Scientific) for at least 2 hr at room temperature. Larvae were cleared in an increasing glycerol row and stored in 70% glycerol in PBS. Larval heads were cut and mounted using Mowiol (Polysciences). Confocal images were acquired using the Leica TCS LSI microscope. Maximum z-projections were created using Fiji ImageJ (<xref ref-type="bibr" rid="bib66">Schindelin et al., 2012</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Although the reported experiments do not need ethical approval, husbandry conditions were approved by local authorities (Veterinäramt Zürich TV4206).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-98634-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Raw data are deposited to Dryad (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.m905qfvd9">https://doi.org/10.5061/dryad.m905qfvd9</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Ronchetti</surname><given-names>R</given-names></name><name><surname>Neuhauss</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Guardian of excitability: Multifaceted role of galanin in whole brain excitability</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.m905qfvd9</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank P Podlasz (University of Warmia and Mazury, Poland) and U Irion (Max Planck Institute, Tübingen) for transgenic lines. We thank M Walther, K Dannenhauer, and H Möckel for excellent technical and animal support and the Neuhauss and Bachmann lab members for valuable discussions. This work was funded by the Swiss National Science Foundation (SNF 31,003 A_135598, 310030_204648) to NNR, MR, ALH, and SCFN and UZH Forschungskredit Candoc Grant K-74417-04-01 to NNR.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>AC</given-names></name><name><surname>Clapham</surname><given-names>JC</given-names></name><name><surname>Wynick</surname><given-names>D</given-names></name><name><surname>Speakman</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference</article-title><source>Journal of Neuroendocrinology</source><volume>20</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.2007.01638.x</pub-id><pub-id pub-id-type="pmid">18088361</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerboom</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>T-W</given-names></name><name><surname>Wardill</surname><given-names>TJ</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Marvin</surname><given-names>JS</given-names></name><name><surname>Mutlu</surname><given-names>S</given-names></name><name><surname>Calderón</surname><given-names>NC</given-names></name><name><surname>Esposti</surname><given-names>F</given-names></name><name><surname>Borghuis</surname><given-names>BG</given-names></name><name><surname>Sun</surname><given-names>XR</given-names></name><name><surname>Gordus</surname><given-names>A</given-names></name><name><surname>Orger</surname><given-names>MB</given-names></name><name><surname>Portugues</surname><given-names>R</given-names></name><name><surname>Engert</surname><given-names>F</given-names></name><name><surname>Macklin</surname><given-names>JJ</given-names></name><name><surname>Filosa</surname><given-names>A</given-names></name><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Kerr</surname><given-names>RA</given-names></name><name><surname>Takagi</surname><given-names>R</given-names></name><name><surname>Kracun</surname><given-names>S</given-names></name><name><surname>Shigetomi</surname><given-names>E</given-names></name><name><surname>Khakh</surname><given-names>BS</given-names></name><name><surname>Baier</surname><given-names>H</given-names></name><name><surname>Lagnado</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>SS-H</given-names></name><name><surname>Bargmann</surname><given-names>CI</given-names></name><name><surname>Kimmel</surname><given-names>BE</given-names></name><name><surname>Jayaraman</surname><given-names>V</given-names></name><name><surname>Svoboda</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Schreiter</surname><given-names>ER</given-names></name><name><surname>Looger</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Optimization of a GCaMP calcium indicator for neural activity imaging</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>13819</fpage><lpage>13840</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2601-12.2012</pub-id><pub-id pub-id-type="pmid">23035093</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>AS</given-names></name><name><surname>Berkovic</surname><given-names>SF</given-names></name><name><surname>Cossette</surname><given-names>P</given-names></name><name><surname>Delanty</surname><given-names>N</given-names></name><name><surname>Dlugos</surname><given-names>D</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Epstein</surname><given-names>MP</given-names></name><name><surname>Glauser</surname><given-names>T</given-names></name><name><surname>Goldstein</surname><given-names>DB</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Heinzen</surname><given-names>EL</given-names></name><name><surname>Hitomi</surname><given-names>Y</given-names></name><name><surname>Howell</surname><given-names>KB</given-names></name><name><surname>Johnson</surname><given-names>MR</given-names></name><name><surname>Kuzniecky</surname><given-names>R</given-names></name><name><surname>Lowenstein</surname><given-names>DH</given-names></name><name><surname>Lu</surname><given-names>Y-F</given-names></name><name><surname>Madou</surname><given-names>MRZ</given-names></name><name><surname>Marson</surname><given-names>AG</given-names></name><name><surname>Mefford</surname><given-names>HC</given-names></name><name><surname>Esmaeeli Nieh</surname><given-names>S</given-names></name><name><surname>O’Brien</surname><given-names>TJ</given-names></name><name><surname>Ottman</surname><given-names>R</given-names></name><name><surname>Petrovski</surname><given-names>S</given-names></name><name><surname>Poduri</surname><given-names>A</given-names></name><name><surname>Ruzzo</surname><given-names>EK</given-names></name><name><surname>Scheffer</surname><given-names>IE</given-names></name><name><surname>Sherr</surname><given-names>EH</given-names></name><name><surname>Yuskaitis</surname><given-names>CJ</given-names></name><name><surname>Abou-Khalil</surname><given-names>B</given-names></name><name><surname>Alldredge</surname><given-names>BK</given-names></name><name><surname>Bautista</surname><given-names>JF</given-names></name><name><surname>Berkovic</surname><given-names>SF</given-names></name><name><surname>Boro</surname><given-names>A</given-names></name><name><surname>Cascino</surname><given-names>GD</given-names></name><name><surname>Consalvo</surname><given-names>D</given-names></name><name><surname>Crumrine</surname><given-names>P</given-names></name><name><surname>Devinsky</surname><given-names>O</given-names></name><name><surname>Dlugos</surname><given-names>D</given-names></name><name><surname>Epstein</surname><given-names>MP</given-names></name><name><surname>Fiol</surname><given-names>M</given-names></name><name><surname>Fountain</surname><given-names>NB</given-names></name><name><surname>French</surname><given-names>J</given-names></name><name><surname>Friedman</surname><given-names>D</given-names></name><name><surname>Geller</surname><given-names>EB</given-names></name><name><surname>Glauser</surname><given-names>T</given-names></name><name><surname>Glynn</surname><given-names>S</given-names></name><name><surname>Haut</surname><given-names>SR</given-names></name><name><surname>Hayward</surname><given-names>J</given-names></name><name><surname>Helmers</surname><given-names>SL</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Kanner</surname><given-names>A</given-names></name><name><surname>Kirsch</surname><given-names>HE</given-names></name><name><surname>Knowlton</surname><given-names>RC</given-names></name><name><surname>Kossoff</surname><given-names>EH</given-names></name><name><surname>Kuperman</surname><given-names>R</given-names></name><name><surname>Kuzniecky</surname><given-names>R</given-names></name><name><surname>Lowenstein</surname><given-names>DH</given-names></name><name><surname>McGuire</surname><given-names>SM</given-names></name><name><surname>Motika</surname><given-names>PV</given-names></name><name><surname>Novotny</surname><given-names>EJ</given-names></name><name><surname>Ottman</surname><given-names>R</given-names></name><name><surname>Paolicchi</surname><given-names>JM</given-names></name><name><surname>Parent</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Poduri</surname><given-names>A</given-names></name><name><surname>Scheffer</surname><given-names>IE</given-names></name><name><surname>Shellhaas</surname><given-names>RA</given-names></name><name><surname>Sherr</surname><given-names>EH</given-names></name><name><surname>Shih</surname><given-names>JJ</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Sirven</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>MC</given-names></name><name><surname>Sullivan</surname><given-names>J</given-names></name><name><surname>Lin Thio</surname><given-names>L</given-names></name><name><surname>Venkat</surname><given-names>A</given-names></name><name><surname>Vining</surname><given-names>EPG</given-names></name><name><surname>Von Allmen</surname><given-names>GK</given-names></name><name><surname>Weisenberg</surname><given-names>JL</given-names></name><name><surname>Widdess-Walsh</surname><given-names>P</given-names></name><name><surname>Winawer</surname><given-names>MR</given-names></name><collab>Epi4K Consortium</collab><collab>Epilepsy Phenome/Genome Project</collab></person-group><year iso-8601-date="2013">2013</year><article-title>De novo mutations in epileptic encephalopathies</article-title><source>Nature</source><volume>501</volume><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1038/nature12439</pub-id><pub-id pub-id-type="pmid">23934111</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>LE</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>McKay</surname><given-names>F</given-names></name><name><surname>Vandewyer</surname><given-names>E</given-names></name><name><surname>Viau</surname><given-names>C</given-names></name><name><surname>Irvine</surname><given-names>A</given-names></name><name><surname>Rosa</surname><given-names>BA</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Marks</surname><given-names>NJ</given-names></name><name><surname>Maule</surname><given-names>AG</given-names></name><name><surname>Mitreva</surname><given-names>M</given-names></name><name><surname>Beets</surname><given-names>I</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Mousley</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>Ascaris suum</italic> Informs extrasynaptic volume transmission in nematodes</article-title><source>ACS Chemical Neuroscience</source><volume>12</volume><fpage>3176</fpage><lpage>3188</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.1c00281</pub-id><pub-id pub-id-type="pmid">34347433</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraban</surname><given-names>SC</given-names></name><name><surname>Taylor</surname><given-names>MR</given-names></name><name><surname>Castro</surname><given-names>PA</given-names></name><name><surname>Baier</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression</article-title><source>Neuroscience</source><volume>131</volume><fpage>759</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.11.031</pub-id><pub-id pub-id-type="pmid">15730879</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraban</surname><given-names>SC</given-names></name><name><surname>Dinday</surname><given-names>MT</given-names></name><name><surname>Castro</surname><given-names>PA</given-names></name><name><surname>Chege</surname><given-names>S</given-names></name><name><surname>Guyenet</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A large-scale mutagenesis screen to identify seizure-resistant zebrafish</article-title><source>Epilepsia</source><volume>48</volume><fpage>1151</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01075.x</pub-id><pub-id pub-id-type="pmid">17521353</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraban</surname><given-names>SC</given-names></name><name><surname>Dinday</surname><given-names>MT</given-names></name><name><surname>Hortopan</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment</article-title><source>Nature Communications</source><volume>4</volume><elocation-id>2410</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms3410</pub-id><pub-id pub-id-type="pmid">24002024</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>IL</given-names></name><name><surname>Rihel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Zebrafish sleep: from geneZZZ to neuronZZZ</article-title><source>Current Opinion in Neurobiology</source><volume>44</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2017.02.009</pub-id><pub-id pub-id-type="pmid">28391130</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T-W</given-names></name><name><surname>Wardill</surname><given-names>TJ</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Pulver</surname><given-names>SR</given-names></name><name><surname>Renninger</surname><given-names>SL</given-names></name><name><surname>Baohan</surname><given-names>A</given-names></name><name><surname>Schreiter</surname><given-names>ER</given-names></name><name><surname>Kerr</surname><given-names>RA</given-names></name><name><surname>Orger</surname><given-names>MB</given-names></name><name><surname>Jayaraman</surname><given-names>V</given-names></name><name><surname>Looger</surname><given-names>LL</given-names></name><name><surname>Svoboda</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ultrasensitive fluorescent proteins for imaging neuronal activity</article-title><source>Nature</source><volume>499</volume><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1038/nature12354</pub-id><pub-id pub-id-type="pmid">23868258</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradi</surname><given-names>L</given-names></name><name><surname>Bruzzone</surname><given-names>M</given-names></name><name><surname>Maschio</surname><given-names>MD</given-names></name><name><surname>Sawamiphak</surname><given-names>S</given-names></name><name><surname>Filosa</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Hypothalamic Galanin-producing neurons regulate stress in zebrafish through a peptidergic, self-inhibitory loop</article-title><source>Current Biology</source><volume>32</volume><fpage>1497</fpage><lpage>1510</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2022.02.011</pub-id><pub-id pub-id-type="pmid">35219430</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>WW</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>Stimulus-secretion coupling: the concept and clues from chromaffin and other cells</article-title><source>British Journal of Pharmacology</source><volume>34</volume><fpage>451</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.1968.tb08474.x</pub-id><pub-id pub-id-type="pmid">4882190</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drexel</surname><given-names>M</given-names></name><name><surname>Sternberg’</surname><given-names>F</given-names></name><name><surname>Kofler</surname><given-names>B</given-names></name><name><surname>Sperk</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Effects of galanin receptor 2 and receptor 3 knockout in mouse models of acute seizures</article-title><source>Epilepsia</source><volume>59</volume><fpage>e166</fpage><lpage>e171</lpage><pub-id pub-id-type="doi">10.1111/epi.14573</pub-id><pub-id pub-id-type="pmid">30298565</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott-Hunt</surname><given-names>CR</given-names></name><name><surname>Marsh</surname><given-names>B</given-names></name><name><surname>Bacon</surname><given-names>A</given-names></name><name><surname>Pope</surname><given-names>R</given-names></name><name><surname>Vanderplank</surname><given-names>P</given-names></name><name><surname>Wynick</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Galanin acts as a neuroprotective factor to the hippocampus</article-title><source>PNAS</source><volume>101</volume><fpage>5105</fpage><lpage>5110</lpage><pub-id pub-id-type="doi">10.1073/pnas.0304823101</pub-id><pub-id pub-id-type="pmid">15041741</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Epi4K Consortium</collab></person-group><year iso-8601-date="2016">2016</year><article-title>De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies</article-title><source>American Journal of Human Genetics</source><volume>99</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.003</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskova</surname><given-names>A</given-names></name><name><surname>Frohnhöfer</surname><given-names>HG</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name><name><surname>Irion</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Galanin signaling in the brain regulates color pattern formation in zebrafish</article-title><source>Current Biology</source><volume>30</volume><fpage>298</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2019.11.033</pub-id><pub-id pub-id-type="pmid">31902721</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettinger</surname><given-names>AB</given-names></name><name><surname>Weisbrot</surname><given-names>DM</given-names></name><name><surname>Nolan</surname><given-names>E</given-names></name><name><surname>Devinsky</surname><given-names>O</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Postictal symptoms help distinguish patients with epileptic seizures from those with non-epileptic seizures</article-title><source>Seizure</source><volume>8</volume><fpage>149</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1053/seiz.1999.0270</pub-id><pub-id pub-id-type="pmid">10356371</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fetissov</surname><given-names>SO</given-names></name><name><surname>Jacoby</surname><given-names>AS</given-names></name><name><surname>Brumovsky</surname><given-names>PR</given-names></name><name><surname>Shine</surname><given-names>J</given-names></name><name><surname>Iismaa</surname><given-names>TP</given-names></name><name><surname>Hökfelt</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice</article-title><source>Epilepsia</source><volume>44</volume><fpage>1022</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1046/j.1528-1157.2003.51402.x</pub-id><pub-id pub-id-type="pmid">12887433</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaus</surname><given-names>SE</given-names></name><name><surname>Strecker</surname><given-names>RE</given-names></name><name><surname>Tate</surname><given-names>BA</given-names></name><name><surname>Parker</surname><given-names>RA</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species</article-title><source>Neuroscience</source><volume>115</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/s0306-4522(02)00308-1</pub-id><pub-id pub-id-type="pmid">12401341</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guella</surname><given-names>I</given-names></name><name><surname>McKenzie</surname><given-names>MB</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Buerki</surname><given-names>SE</given-names></name><name><surname>Toyota</surname><given-names>EB</given-names></name><name><surname>Van Allen</surname><given-names>MI</given-names></name><collab>Epilepsy Genomics Study</collab><name><surname>Suri</surname><given-names>M</given-names></name><name><surname>Elmslie</surname><given-names>F</given-names></name><collab>Deciphering Developmental Disorders Study</collab><name><surname>Simon</surname><given-names>MEH</given-names></name><name><surname>van Gassen</surname><given-names>KLI</given-names></name><name><surname>Héron</surname><given-names>D</given-names></name><name><surname>Keren</surname><given-names>B</given-names></name><name><surname>Nava</surname><given-names>C</given-names></name><name><surname>Connolly</surname><given-names>MB</given-names></name><name><surname>Demos</surname><given-names>M</given-names></name><name><surname>Farrer</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>De novo mutations in YWHAG cause early-onset epilepsy</article-title><source>American Journal of Human Genetics</source><volume>101</volume><fpage>300</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.07.004</pub-id><pub-id pub-id-type="pmid">28777935</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamelin</surname><given-names>S</given-names></name><name><surname>Kahane</surname><given-names>P</given-names></name><name><surname>Vercueil</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fatigue in epilepsy: a prospective inter-ictal and post-ictal survey</article-title><source>Epilepsy Research</source><volume>91</volume><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.eplepsyres.2010.07.006</pub-id><pub-id pub-id-type="pmid">20708384</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendricks</surname><given-names>JC</given-names></name><name><surname>Finn</surname><given-names>SM</given-names></name><name><surname>Panckeri</surname><given-names>KA</given-names></name><name><surname>Chavkin</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>JA</given-names></name><name><surname>Sehgal</surname><given-names>A</given-names></name><name><surname>Pack</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Rest in <italic>Drosophila</italic> is a sleep-like state</article-title><source>Neuron</source><volume>25</volume><fpage>129</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80877-6</pub-id><pub-id pub-id-type="pmid">10707978</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hökfelt</surname><given-names>T</given-names></name><name><surname>Barde</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Z-QD</given-names></name><name><surname>Kuteeva</surname><given-names>E</given-names></name><name><surname>Rüegg</surname><given-names>J</given-names></name><name><surname>Le Maitre</surname><given-names>E</given-names></name><name><surname>Risling</surname><given-names>M</given-names></name><name><surname>Kehr</surname><given-names>J</given-names></name><name><surname>Ihnatko</surname><given-names>R</given-names></name><name><surname>Theodorsson</surname><given-names>E</given-names></name><name><surname>Palkovits</surname><given-names>M</given-names></name><name><surname>Deakin</surname><given-names>W</given-names></name><name><surname>Bagdy</surname><given-names>G</given-names></name><name><surname>Juhasz</surname><given-names>G</given-names></name><name><surname>Prud’homme</surname><given-names>HJ</given-names></name><name><surname>Mechawar</surname><given-names>N</given-names></name><name><surname>Diaz-Heijtz</surname><given-names>R</given-names></name><name><surname>Ögren</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuropeptide and small transmitter coexistence: fundamental studies and relevance to mental illness</article-title><source>Frontiers in Neural Circuits</source><volume>12</volume><elocation-id>106</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2018.00106</pub-id><pub-id pub-id-type="pmid">30627087</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hortopan</surname><given-names>GA</given-names></name><name><surname>Dinday</surname><given-names>MT</given-names></name><name><surname>Baraban</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>13718</fpage><lpage>13728</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1887-10.2010</pub-id><pub-id pub-id-type="pmid">20943912</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotz</surname><given-names>AL</given-names></name><name><surname>Jamali</surname><given-names>A</given-names></name><name><surname>Rieser</surname><given-names>NN</given-names></name><name><surname>Niklaus</surname><given-names>S</given-names></name><name><surname>Aydin</surname><given-names>E</given-names></name><name><surname>Myren-Svelstad</surname><given-names>S</given-names></name><name><surname>Lalla</surname><given-names>L</given-names></name><name><surname>Jurisch-Yaksi</surname><given-names>N</given-names></name><name><surname>Yaksi</surname><given-names>E</given-names></name><name><surname>Neuhauss</surname><given-names>SCF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures, and basal hypoactivity</article-title><source>Glia</source><volume>70</volume><fpage>196</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1002/glia.24106</pub-id><pub-id pub-id-type="pmid">34716961</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacoby</surname><given-names>AS</given-names></name><name><surname>Hort</surname><given-names>YJ</given-names></name><name><surname>Constantinescu</surname><given-names>G</given-names></name><name><surname>Shine</surname><given-names>J</given-names></name><name><surname>Iismaa</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity</article-title><source>Brain Research. Molecular Brain Research</source><volume>107</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/s0169-328x(02)00451-5</pub-id><pub-id pub-id-type="pmid">12487125</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jan</surname><given-names>LY</given-names></name><name><surname>Jan</surname><given-names>YN</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Peptidergic transmission in sympathetic ganglia of the frog</article-title><source>The Journal of Physiology</source><volume>327</volume><fpage>219</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1982.sp014228</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhasz</surname><given-names>G</given-names></name><name><surname>Hullam</surname><given-names>G</given-names></name><name><surname>Eszlari</surname><given-names>N</given-names></name><name><surname>Gonda</surname><given-names>X</given-names></name><name><surname>Antal</surname><given-names>P</given-names></name><name><surname>Anderson</surname><given-names>IM</given-names></name><name><surname>Hökfelt</surname><given-names>TGM</given-names></name><name><surname>Deakin</surname><given-names>JFW</given-names></name><name><surname>Bagdy</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Brain galanin system genes interact with life stresses in depression-related phenotypes</article-title><source>PNAS</source><volume>111</volume><fpage>E1666</fpage><lpage>E1673</lpage><pub-id pub-id-type="doi">10.1073/pnas.1403649111</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoshbouei</surname><given-names>H</given-names></name><name><surname>Cecchi</surname><given-names>M</given-names></name><name><surname>Morilak</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress</article-title><source>Neuropsychopharmacology</source><volume>27</volume><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(01)00424-9</pub-id><pub-id pub-id-type="pmid">12062904</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D-K</given-names></name><name><surname>Yun</surname><given-names>S</given-names></name><name><surname>Son</surname><given-names>GH</given-names></name><name><surname>Hwang</surname><given-names>J-I</given-names></name><name><surname>Park</surname><given-names>CR</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Vaudry</surname><given-names>H</given-names></name><name><surname>Seong</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III</article-title><source>Endocrinology</source><volume>155</volume><fpage>1864</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1210/en.2013-2106</pub-id><pub-id pub-id-type="pmid">24517231</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohl</surname><given-names>J</given-names></name><name><surname>Babayan</surname><given-names>BM</given-names></name><name><surname>Rubinstein</surname><given-names>ND</given-names></name><name><surname>Autry</surname><given-names>AE</given-names></name><name><surname>Marin-Rodriguez</surname><given-names>B</given-names></name><name><surname>Kapoor</surname><given-names>V</given-names></name><name><surname>Miyamishi</surname><given-names>K</given-names></name><name><surname>Zweifel</surname><given-names>LS</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Uchida</surname><given-names>N</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional circuit architecture underlying parental behaviour</article-title><source>Nature</source><volume>556</volume><fpage>326</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0027-0</pub-id><pub-id pub-id-type="pmid">29643503</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaia</surname><given-names>M</given-names></name><name><surname>Holmberg</surname><given-names>K</given-names></name><name><surname>Nanobashvili</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>ZQ</given-names></name><name><surname>Kokaia</surname><given-names>Z</given-names></name><name><surname>Lendahl</surname><given-names>U</given-names></name><name><surname>Hilke</surname><given-names>S</given-names></name><name><surname>Theodorsson</surname><given-names>E</given-names></name><name><surname>Kahl</surname><given-names>U</given-names></name><name><surname>Bartfai</surname><given-names>T</given-names></name><name><surname>Lindvall</surname><given-names>O</given-names></name><name><surname>Hökfelt</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin</article-title><source>PNAS</source><volume>98</volume><fpage>14006</fpage><lpage>14011</lpage><pub-id pub-id-type="doi">10.1073/pnas.231496298</pub-id><pub-id pub-id-type="pmid">11698649</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovac</surname><given-names>S</given-names></name><name><surname>Walker</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neuropeptides in epilepsy</article-title><source>Neuropeptides</source><volume>47</volume><fpage>467</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.npep.2013.10.015</pub-id><pub-id pub-id-type="pmid">24210141</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroeger</surname><given-names>D</given-names></name><name><surname>Absi</surname><given-names>G</given-names></name><name><surname>Gagliardi</surname><given-names>C</given-names></name><name><surname>Bandaru</surname><given-names>SS</given-names></name><name><surname>Madara</surname><given-names>JC</given-names></name><name><surname>Ferrari</surname><given-names>LL</given-names></name><name><surname>Arrigoni</surname><given-names>E</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name><name><surname>Scammell</surname><given-names>TE</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Vetrivelan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Galanin neurons in the ventrolateral preoptic area promote sleep and heat loss in mice</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4129</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06590-7</pub-id><pub-id pub-id-type="pmid">30297727</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>F</given-names></name><name><surname>Powell</surname><given-names>GT</given-names></name><name><surname>Ghosh</surname><given-names>M</given-names></name><name><surname>Gestri</surname><given-names>G</given-names></name><name><surname>Antinucci</surname><given-names>P</given-names></name><name><surname>Hearn</surname><given-names>TJ</given-names></name><name><surname>Tunbak</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Dennis</surname><given-names>HW</given-names></name><name><surname>Fernandez</surname><given-names>JM</given-names></name><name><surname>Whitmore</surname><given-names>D</given-names></name><name><surname>Dreosti</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name><name><surname>Hoffman</surname><given-names>EJ</given-names></name><name><surname>Rihel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A simple and effective F0 knockout method for rapid screening of behaviour and other complex phenotypes</article-title><source>eLife</source><volume>10</volume><elocation-id>e59683</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.59683</pub-id><pub-id pub-id-type="pmid">33416493</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>F</given-names></name><name><surname>Rihel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>F0 knockout—single gene</article-title><ext-link ext-link-type="uri" xlink:href="https://www.protocols.io/view/f0-knockout-single-gene-5qpvo52wdl4o/v1">https://www.protocols.io/view/f0-knockout-single-gene-5qpvo52wdl4o/v1</ext-link><date-in-citation iso-8601-date="2020-11-12">November 12, 2020</date-in-citation></element-citation></ref><ref id="bib36"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>How to select the best gRNA(s) for frameshift knockouts in zebrafish v1</article-title><ext-link ext-link-type="uri" xlink:href="https://www.protocols.io/view/how-to-select-the-best-grna-s-for-frameshift-knock-81wgb6r5qlpk/v1">https://www.protocols.io/view/how-to-select-the-best-grna-s-for-frameshift-knock-81wgb6r5qlpk/v1</ext-link><date-in-citation iso-8601-date="2022-04-01">April 1, 2022</date-in-citation></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labun</surname><given-names>K</given-names></name><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><name><surname>Torres Cleuren</surname><given-names>YN</given-names></name><name><surname>Tjeldnes</surname><given-names>H</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W171</fpage><lpage>W174</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz365</pub-id><pub-id pub-id-type="pmid">31106371</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>Gundlach</surname><given-names>AL</given-names></name><name><surname>Holmes</surname><given-names>FE</given-names></name><name><surname>Hobson</surname><given-names>SA</given-names></name><name><surname>Wynick</surname><given-names>D</given-names></name><name><surname>Hökfelt</surname><given-names>T</given-names></name><name><surname>Kofler</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity</article-title><source>Pharmacological Reviews</source><volume>67</volume><fpage>118</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1124/pr.112.006536</pub-id><pub-id pub-id-type="pmid">25428932</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laque</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Qualls-Creekmore</surname><given-names>E</given-names></name><name><surname>Gettys</surname><given-names>S</given-names></name><name><surname>Schwartzenburg</surname><given-names>C</given-names></name><name><surname>Bui</surname><given-names>K</given-names></name><name><surname>Rhodes</surname><given-names>C</given-names></name><name><surname>Berthoud</surname><given-names>H-R</given-names></name><name><surname>Morrison</surname><given-names>CD</given-names></name><name><surname>Richards</surname><given-names>BK</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Leptin modulates nutrient reward via inhibitory galanin action on orexin neurons</article-title><source>Molecular Metabolism</source><volume>4</volume><fpage>706</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2015.07.002</pub-id><pub-id pub-id-type="pmid">26500842</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leibowitz</surname><given-names>SF</given-names></name><name><surname>Akabayashi</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>2709</fpage><lpage>2719</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-07-02709.1998</pub-id><pub-id pub-id-type="pmid">9502828</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>JT</given-names></name><name><surname>Sankar</surname><given-names>R</given-names></name><name><surname>Mazarati</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Galanin and epilepsy</article-title><source>Cellular and Molecular Life Sciences</source><volume>65</volume><fpage>1864</fpage><lpage>1871</lpage><pub-id pub-id-type="doi">10.1007/s00018-008-8161-8</pub-id><pub-id pub-id-type="pmid">18500639</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A novel galanin receptor 1a gene in zebrafish: Tissue distribution, developmental expression roles in nutrition regulation</article-title><source>Comparative Biochemistry and Physiology Part B</source><volume>164</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.cbpb.2012.12.004</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Spikings</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Rawson</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Housekeeping genes for cryopreservation studies on zebrafish embryos and blastomeres</article-title><source>Theriogenology</source><volume>71</volume><fpage>1147</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1016/j.theriogenology.2008.12.013</pub-id><pub-id pub-id-type="pmid">19201018</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Witvliet</surname><given-names>D</given-names></name><name><surname>Hernandez-Nunez</surname><given-names>L</given-names></name><name><surname>Linderman</surname><given-names>SW</given-names></name><name><surname>Samuel</surname><given-names>ADT</given-names></name><name><surname>Venkatachalam</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Imaging whole-brain activity to understand behavior</article-title><source>Nature Reviews. Physics</source><volume>4</volume><fpage>292</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/s42254-022-00430-w</pub-id><pub-id pub-id-type="pmid">37409001</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Greco</surname><given-names>MA</given-names></name><name><surname>Shiromani</surname><given-names>P</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>3830</fpage><lpage>3842</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-10-03830.2000</pub-id><pub-id pub-id-type="pmid">10804223</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Tong</surname><given-names>YG</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>W</given-names></name><name><surname>Payza</surname><given-names>K</given-names></name><name><surname>Hodzic</surname><given-names>L</given-names></name><name><surname>Pou</surname><given-names>C</given-names></name><name><surname>Godbout</surname><given-names>C</given-names></name><name><surname>Hökfelt</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>ZQ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Effects of galanin receptor agonists on locus coeruleus neurons</article-title><source>Brain Research</source><volume>919</volume><fpage>169</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/s0006-8993(01)03033-5</pub-id><pub-id pub-id-type="pmid">11689176</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Miracca</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Harding</surname><given-names>EC</given-names></name><name><surname>Miao</surname><given-names>A</given-names></name><name><surname>Yustos</surname><given-names>R</given-names></name><name><surname>Vyssotski</surname><given-names>AL</given-names></name><name><surname>Franks</surname><given-names>NP</given-names></name><name><surname>Wisden</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Galanin neurons unite sleep homeostasis and α2-adrenergic sedation</article-title><source>Current Biology</source><volume>29</volume><fpage>3315</fpage><lpage>3322</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2019.07.087</pub-id><pub-id pub-id-type="pmid">31543455</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacArthur</surname><given-names>L</given-names></name><name><surname>Eiden</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Neuropeptide genes: targets of activity-dependent signal transduction</article-title><source>Peptides</source><volume>17</volume><fpage>721</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/0196-9781(95)02100-0</pub-id><pub-id pub-id-type="pmid">8804085</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazarati</surname><given-names>AM</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Soomets</surname><given-names>U</given-names></name><name><surname>Sankar</surname><given-names>R</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Katsumori</surname><given-names>H</given-names></name><name><surname>Langel</surname><given-names>U</given-names></name><name><surname>Wasterlain</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>10070</fpage><lpage>10077</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-23-10070.1998</pub-id><pub-id pub-id-type="pmid">9822761</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazarati</surname><given-names>AM</given-names></name><name><surname>Hohmann</surname><given-names>JG</given-names></name><name><surname>Bacon</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Sankar</surname><given-names>R</given-names></name><name><surname>Steiner</surname><given-names>RA</given-names></name><name><surname>Wynick</surname><given-names>D</given-names></name><name><surname>Wasterlain</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Modulation of hippocampal excitability and seizures by galanin</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>6276</fpage><lpage>6281</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-16-06276.2000</pub-id><pub-id pub-id-type="pmid">10934278</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McColl</surname><given-names>CD</given-names></name><name><surname>Jacoby</surname><given-names>AS</given-names></name><name><surname>Shine</surname><given-names>J</given-names></name><name><surname>Iismaa</surname><given-names>TP</given-names></name><name><surname>Bekkers</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus</article-title><source>Neuropharmacology</source><volume>50</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2005.09.001</pub-id><pub-id pub-id-type="pmid">16243364</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinty</surname><given-names>D</given-names></name><name><surname>Szymusiak</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Hypothalamic regulation of sleep and arousal</article-title><source>Frontiers in Bioscience</source><volume>8</volume><fpage>s1074</fpage><lpage>s1083</lpage><pub-id pub-id-type="doi">10.2741/1159</pub-id><pub-id pub-id-type="pmid">12957869</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>MC</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate</article-title><source>Current Biology</source><volume>4</volume><fpage>189</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(00)00048-8</pub-id><pub-id pub-id-type="pmid">7922324</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nässel</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neuropeptide signaling near and far: how localized and timed is the action of neuropeptides in brain circuits?</article-title><source>Invertebrate Neuroscience</source><volume>9</volume><fpage>57</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/s10158-009-0090-1</pub-id><pub-id pub-id-type="pmid">19756790</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parslow</surname><given-names>A</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name><name><surname>Bryson-Richardson</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sample drift correction following 4D confocal time-lapse imaging</article-title><source>Journal of Visualized Experiments</source><volume>10</volume><elocation-id>3791</elocation-id><pub-id pub-id-type="doi">10.3791/51086</pub-id><pub-id pub-id-type="pmid">24747942</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picciotto</surname><given-names>MR</given-names></name><name><surname>Brabant</surname><given-names>C</given-names></name><name><surname>Einstein</surname><given-names>EB</given-names></name><name><surname>Kamens</surname><given-names>HM</given-names></name><name><surname>Neugebauer</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors</article-title><source>Brain Research</source><volume>1314</volume><fpage>206</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2009.08.033</pub-id><pub-id pub-id-type="pmid">19699187</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podlasz</surname><given-names>P</given-names></name><name><surname>Jakimiuk</surname><given-names>A</given-names></name><name><surname>Kasica-Jarosz</surname><given-names>N</given-names></name><name><surname>Czaja</surname><given-names>K</given-names></name><name><surname>Wasowicz</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuroanatomical localization of galanin in zebrafish telencephalon and anticonvulsant effect of galanin overexpression</article-title><source>ACS Chemical Neuroscience</source><volume>9</volume><fpage>3049</fpage><lpage>3059</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.8b00239</pub-id><pub-id pub-id-type="pmid">30095254</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Posit team</collab></person-group><year iso-8601-date="2023">2023</year><data-title>RStudio: integrated development environment for r</data-title><source>Allairejj</source><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/conferences/useR-2011/abstracts/180111-allairejj.pdf">https://www.r-project.org/conferences/useR-2011/abstracts/180111-allairejj.pdf</ext-link></element-citation></ref><ref id="bib59"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Purves</surname><given-names>D</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name><name><surname>Fitzpatrick</surname><given-names>D</given-names></name><name><surname>Hall</surname><given-names>WC</given-names></name><name><surname>LaMantia</surname><given-names>AS</given-names></name><name><surname>Mooney</surname><given-names>RD</given-names></name><name><surname>Platt</surname><given-names>ML</given-names></name><name><surname>White</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>Neuroscience</source><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qualls-Creekmore</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Francois</surname><given-names>M</given-names></name><name><surname>Hoang</surname><given-names>J</given-names></name><name><surname>Huesing</surname><given-names>C</given-names></name><name><surname>Bruce-Keller</surname><given-names>A</given-names></name><name><surname>Burk</surname><given-names>D</given-names></name><name><surname>Berthoud</surname><given-names>H-R</given-names></name><name><surname>Morrison</surname><given-names>CD</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Galanin-expressing GABA neurons in the lateral hypothalamus modulate food reward and noncompulsive locomotion</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>6053</fpage><lpage>6065</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0155-17.2017</pub-id><pub-id pub-id-type="pmid">28539422</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raizen</surname><given-names>DM</given-names></name><name><surname>Zimmerman</surname><given-names>JE</given-names></name><name><surname>Maycock</surname><given-names>MH</given-names></name><name><surname>Ta</surname><given-names>UD</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Sundaram</surname><given-names>MV</given-names></name><name><surname>Pack</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Lethargus is a <italic>Caenorhabditis elegans</italic> sleep-like state</article-title><source>Nature</source><volume>451</volume><fpage>569</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1038/nature06535</pub-id><pub-id pub-id-type="pmid">18185515</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2022">2022</year><data-title>R: a language andenvironment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org">https://www.r-project.org</ext-link></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichert</surname><given-names>S</given-names></name><name><surname>Pavón Arocas</surname><given-names>O</given-names></name><name><surname>Rihel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The neuropeptide galanin is required for homeostatic rebound sleep following increased neuronal activity</article-title><source>Neuron</source><volume>104</volume><fpage>370</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.08.010</pub-id><pub-id pub-id-type="pmid">31537465</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripoll-Sánchez</surname><given-names>L</given-names></name><name><surname>Watteyne</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Fernandez</surname><given-names>R</given-names></name><name><surname>Taylor</surname><given-names>SR</given-names></name><name><surname>Weinreb</surname><given-names>A</given-names></name><name><surname>Bentley</surname><given-names>BL</given-names></name><name><surname>Hammarlund</surname><given-names>M</given-names></name><name><surname>Hobert</surname><given-names>O</given-names></name><name><surname>Beets</surname><given-names>I</given-names></name><name><surname>Vértes</surname><given-names>PE</given-names></name><name><surname>Schafer</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The neuropeptidergic connectome of <italic>C. elegans</italic></article-title><source>Neuron</source><volume>111</volume><fpage>3570</fpage><lpage>3589</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.09.043</pub-id><pub-id pub-id-type="pmid">37935195</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schick</surname><given-names>RR</given-names></name><name><surname>Samsami</surname><given-names>S</given-names></name><name><surname>Zimmermann</surname><given-names>JP</given-names></name><name><surname>Eberl</surname><given-names>T</given-names></name><name><surname>Endres</surname><given-names>C</given-names></name><name><surname>Schusdziarra</surname><given-names>V</given-names></name><name><surname>Classen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites</article-title><source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source><volume>264</volume><fpage>R355</fpage><lpage>R361</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.1993.264.2.R355</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>J-Y</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillage</surname><given-names>RP</given-names></name><name><surname>Wilson</surname><given-names>GE</given-names></name><name><surname>Liles</surname><given-names>LC</given-names></name><name><surname>Holmes</surname><given-names>PV</given-names></name><name><surname>Weinshenker</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Chronic environmental or genetic elevation of galanin in noradrenergic neurons confers stress resilience in mice</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>7464</fpage><lpage>7474</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0973-20.2020</pub-id><pub-id pub-id-type="pmid">32868458</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillage</surname><given-names>RP</given-names></name><name><surname>Foster</surname><given-names>SL</given-names></name><name><surname>Lustberg</surname><given-names>D</given-names></name><name><surname>Liles</surname><given-names>LC</given-names></name><name><surname>McCann</surname><given-names>KE</given-names></name><name><surname>Weinshenker</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Co-released norepinephrine and galanin act on different timescales to promote stress-induced anxiety-like behavior</article-title><source>Neuropsychopharmacology</source><volume>46</volume><fpage>1535</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1038/s41386-021-01011-8</pub-id><pub-id pub-id-type="pmid">33911187</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Alphen</surname><given-names>B</given-names></name><name><surname>Yap</surname><given-names>MHW</given-names></name><name><surname>Kirszenblat</surname><given-names>L</given-names></name><name><surname>Kottler</surname><given-names>B</given-names></name><name><surname>van Swinderen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A dynamic deep sleep stage in <italic>Drosophila</italic></article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>6917</fpage><lpage>6927</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0061-13.2013</pub-id><pub-id pub-id-type="pmid">23595750</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Pol</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neuropeptide transmission in brain circuits</article-title><source>Neuron</source><volume>76</volume><fpage>98</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.014</pub-id><pub-id pub-id-type="pmid">23040809</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>IG</given-names></name><name><surname>Schoppik</surname><given-names>D</given-names></name><name><surname>Shi</surname><given-names>VJ</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Coleman</surname><given-names>HA</given-names></name><name><surname>Greenwood</surname><given-names>J</given-names></name><name><surname>Soucy</surname><given-names>ER</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuropeptidergic signaling partitions arousal behaviors in zebrafish</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>3142</fpage><lpage>3160</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3529-13.2014</pub-id><pub-id pub-id-type="pmid">24573274</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Autry</surname><given-names>AE</given-names></name><name><surname>Bergan</surname><given-names>JF</given-names></name><name><surname>Watabe-Uchida</surname><given-names>M</given-names></name><name><surname>Dulac</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Galanin neurons in the medial preoptic area govern parental behaviour</article-title><source>Nature</source><volume>509</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nature13307</pub-id><pub-id pub-id-type="pmid">24828191</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zini</surname><given-names>S</given-names></name><name><surname>Roisin</surname><given-names>MP</given-names></name><name><surname>Langel</surname><given-names>U</given-names></name><name><surname>Bartfai</surname><given-names>T</given-names></name><name><surname>Ben-Ari</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus</article-title><source>European Journal of Pharmacology</source><volume>245</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/0922-4106(93)90162-3</pub-id><pub-id pub-id-type="pmid">7682961</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98634.4.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Scharfman</surname><given-names>Helen E</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Nathan Kline Institute</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Incomplete</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Useful</kwd></kwd-group></front-stub><body><p>The study investigated the effects of the peptide galanin on brain Ca2+ activity in zebrafish, which provides a <bold>useful</bold> model organism for whole-brain imaging because of its transparency. They found that galanin has distinct effects on hyperactivity and expression of galanin changes after activity increases. The strength of evidence was <bold>incomplete</bold> particularly for some of the conclusions regarding the use of convulsants and relevance to epilepsy because of limitations to the methods and interpretations of results.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98634.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this study, authors explored how galanin affects whole-brain activity in larval zebrafish using wide-field Ca2+ imaging, genetic modifications, and drugs that increase brain activity. The authors conclude that galanin has a sedative effect on the brain under normal conditions and during seizures, mainly through the galanin receptor 1a (galr1a). However, acute &quot;stressors(?)&quot; like pentylenetetrazole (PTZ) reduce galanin's effects, leading to increased brain activity and more seizures. Authors claim that galanin can reduce seizure severity while increasing seizure occurrence, speculated to occur through different receptor subtypes. This study confirms galanin's complex role in brain activity, supporting its potential impact on epilepsy.</p><p>Strengths:</p><p>The overall strength of the study lies primarily in its methodological approach using whole-brain Calcium imaging facilitated by the transparency of zebrafish larvae. Additionally, the use of transgenic zebrafish models is an advantage, as it enables genetic manipulations to investigate specific aspects of galanin signaling. This combination of advanced imaging and genetic tools allows for addressing galanin's role in regulating brain activity.</p><p>Weaknesses:</p><p>We have carefully reviewed the revised manuscript and the authors' responses. While the authors have attempted to address the points raised, I find that the revisions and rebuttals are insufficient and not entirely adequate. The authors seem not to have modified the manuscript in any way to take our comments into account.</p><p>In particular, many of the methodological and conceptual issues I initially raised remain unresolved. For example, the fundamental concern regarding the use of whole-brain calcium imaging - a method that may not effectively capture the localized and network-specific nature of seizure initiation and propagation - has not been adequately addressed. The authors acknowledge some limitations but do not sufficiently discuss how these affect the interpretation of their findings or propose mitigations. This could be added to the discussion section.</p><p>Additionally, the characterization of PTZ as a &quot;stressor&quot; remains problematic. Although the authors have retained this terminology, PTZ is widely understood to act primarily as a proconvulsant agent rather than a general stressor, and framing it otherwise continues to appear like a model-fitting rather than evidence-driven decision. The authors should consider changing the terminology throughout the manuscript and address these concerns when discussing their choice of PTZ as &quot;stressor&quot;.</p><p>The discussion of the EAAT2 mutant model also remains incomplete. Although the authors mention preliminary transcriptome analyses, no new data were included, and it is stated that the evaluation is ongoing. Without thorough gene expression data, alternative explanations for the hypoactivity phenotype (such as changes in AMPA receptor or other critical neurotransmission-related genes) remain plausible and unaddressed. Moreover, the authors' acknowledgement that galanin upregulation is &quot;at best one of a suite of regulatory mechanisms&quot; further diminishes the centrality of their conclusions without sufficiently reworking the narrative of the study.</p><p>Finally, the finding that double knockout animals for EAAT2 and galanin showed little difference in seizure susceptibility compared to EAAT2 knockouts alone suggests that galanin upregulation may not play a dominant functional role, yet this important implication is not adequately reflected in the interpretation of the results.</p><p>Conclusion:</p><p>In summary, although the authors have made some efforts to respond to the critiques, I do not believe the manuscript has been substantially improved in response in R2, and I do not see reason to change my original assessment made after R1. The major conceptual and methodological concerns remain largely unaddressed, limiting the impact and validity of the study's conclusions. These concerns should be addressed not only in the rebuttal letter but also in the manuscript.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98634.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This revised paper describes an investigation of galanin and galanin receptor signaling on whole-brain activity in the context of recurrent seizure activity or under homeostatic basal conditions. The authors primarily use calcium imaging to observe whole-brain neuronal activity accompanied by galanin qPCR to determine how manipulations of galanin or the galr1a receptor affect the activity of the whole-brain under non-ictal conditions or when seizure activity occurs. The authors use their eaat2a-/- model (introduced in their Glia 2022 paper, PMID 34716961) that shows recurrent seizure activity as well as suppression of neuronal activity and locomotion interictally. It is compared to the well-known pentylenetetrazole (PTZ) pharmacological model of seizures in zebrafish. Given the literature cited in their Introduction, the authors hypothesize that galanin will exert a net inhibitory effect on brain activity in models of seizures/epilepsy. They were surprised to find that this hypothesis was only moderately supported in their eaat2a-/- model. In contrast, after PTZ, fish with galanin overexpression showed increased seizure number and reduced duration while fish with galanin KO showed reduced seizure number and increased duration.</p><p>Previous concerns about sex or developmental biological variables were addressed, as their model's seizure phenotype emerges rapidly and long prior to the establishment of zebrafish sexual maturity. However, it remains unclear whether all seizures detected via calcium imaging alone are also seizures that are detectable at the level of animal behavior. To confirm this, a validation of the threshold used for calcium imaging of &quot;neuronal seizures&quot; would be required to determine if this threshold detects only &quot;neuronal seizures&quot; that co-occur with behavioral seizures. Overall, this study is important and convincing, and carries clear value for understanding the multifaceted functions that neuronal galanin can perform under homeostatic and disease conditions.</p><p>Additional Concerns:</p><p>- The authors have validated their ability to measure behavioral seizures quantitatively in their 2022 Glia paper but the information provided on defining behavioral seizures as they map onto seizures detected via imaging alone was limited. The definition of behavioral seizure activity as it relates to calcium fluctuations is not expanded upon in this paper, but could provide detail about how the behavioral seizures relate to a seizure detected via calcium imaging alone.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98634.4.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The neuropeptide galanin is primarily expressed in the hypothalamus and has been shown to play critical roles in homeostatic functions such as arousal, sleep, stress, and brain disorders such as epilepsy. Previous work in rodents using galanin analogs and receptor-specific knockout have provided convincing evidence for anti-convulsant effects of galanin.</p><p>In the present study, the authors sought to determine the relationship between galanin expression and whole-brain activity. The authors took advantage of the transparent nature of larval zebrafish to perform whole-brain neural activity measurements via widefield calcium imaging. Two models of seizures were used (eaat2a-/- and pentylenetetrazol; PTZ). In the eaat2a-/- model, spontaneous seizures occur and the authors found that galanin transcript levels were significantly increased and associated with reduced frequency of calcium events. Similarly, two hours after PTZ galanin transcript levels roughly doubled and the frequency and amplitude of calcium events were reduced, while the duration increased.</p><p>The authors also used a heat shock protein line (hsp70I:gal) where galanin transcripts levels are induced by activation of heat shock protein, but this line also shows higher basal transcript levels of galanin. Due to problems with whole-brain activity in wild-type larvae, the authors used the line without heat shock. They found higher level of galanin in hsp70I:gal larval zebrafish resulted in a reduction in the number of calcium events and amplitude. In contrast, galanin knockout (gal-/-) significantly increased calcium activity, indicated by an increased number of calcium events, but a reduction in amplitude and duration. Antibody staining confirmed the absence of galanin expression in gal-/- knockouts. Knockout of the galanin receptor subtype galr1a via crispants also increased the frequency of calcium events without influencing amplitude or duration.</p><p>In subsequent experiments in eaat2a-/- mutants were crossed with hsp70I:gal or gal-/- to modify galanin expression. These experiments showed modest effects, with eaat2a-/- x gal-/- knockouts showing an increased normalized area under the curve and seizure amplitude.</p><p>Lastly, the authors attempted to study the relationship between galanin and brain activity during a PTZ challenge. The hsp70I:gal larva showed increased number of seizures and reduced seizure duration during PTZ. In contrast, gal-/- mutants showed increased normalized area under the curve and a stark reduction in number of detected seizures, a reduction in seizure amplitude, but an increase in seizure duration. The authors then ruled out the role galanin a1 receptor in modulating this effect during PTZ, since the number of seizures was unaffected, whereas the amplitude and duration of seizures was increased in galr1a knockouts.</p><p>Strengths:</p><p>(1) The gain- and loss-of function galanin manipulations provided convincing evidence that galanin influences brain activity (via calcium imaging) during interictal and/or seizure-free periods. The relationship between galanin transcript levels and brain activity in figures 1 &amp; 2 was convincing. Antibody staining also supports the absence of galanin in gal-/- mutants. Moreover, galanin transcript levels were unchanged in galr1ako brains, suggesting the lack of compensatory effects.</p><p>(2) The authors use two models of epilepsy (eaat2a-/- and PTZ).</p><p>(3) Supplementary video files for calcium imaging support the observations.</p><p>Weaknesses:</p><p>(1) I disagree with the idea that PTZ is a 'stressor'. This was raised in previous reviews and has not been acknowledged sufficiently.</p><p>(2) Although the relationship between galanin and brain activity during interictal or seizure-free periods was clear, the mechanisms that influence excitability during PTZ remain unclear. The authors show that galr1a does not mediate this effect, since seizure amplitude and duration were more severe in galr1a KO. Therefore, it remains unclear which galanin receptor is modulating this inhibitory effect.</p><p>(3) The manuscript is heavily reliant on calcium imaging for interpretation.</p><p>Additional methods could strengthen the data, translational relevance, and interpretation (e.g., acute pharmacology using selective galanin agonists or antagonists, brain or cell recordings, biochemistry, etc).</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98634.4.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rieser</surname><given-names>Nicolas N</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Ronchetti</surname><given-names>Milena</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Hotz</surname><given-names>Adriana Lea Lea</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Neuhauss</surname><given-names>Stephan CF</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews</p><disp-quote content-type="editor-comment"><p><bold>Review 1:</bold></p><p>Weaknesses:</p><p>The weaknesses of the study also stem from the methodological approach, particularly the use of whole-brain Calcium imaging as a measure of brain activity. While epilepsy and seizures involve network interactions, they typically do not originate across the entire brain simultaneously. Seizures often begin in specific regions or even within specific populations of neurons within those regions. Therefore, a whole-brain approach, especially with Calcium imaging with inherited limitations, may not fully capture the localized nature of seizure initiation and propagation, potentially limiting the understanding of Galanin's role in epilepsy.</p></disp-quote><p>We agree with the reviewers that the whole brain imaging approach is both a strength and a weakness. This manuscript and our previously published paper (Hotz et al., 2022) show indeed that the seizures have a initiation point and spread throughout the brain, interestingly affecting the telencephalon last. Localized seizure initiation was not the scope of this manuscript, however also here we would have to rely on imaging techniques. Using cell type specific drivers for specific neuronal subpopulation are an interesting approach, but outside of the scope of this study. An interesting approach would also include a more detailed analysis of glia in the context of epilepsy.</p><disp-quote content-type="editor-comment"><p>Furthermore, Galanin's effects may vary across different brain areas, likely influenced by the predominant receptor types expressed in those regions. Additionally, the use of PTZ as a &quot;stressor&quot; is questionable since PTZ induces seizures rather than conventional stress. Referring to seizures induced by PTZ as &quot;stress&quot; might be a misinterpretation intended to fit the proposed model of stress regulation by receptors other than Galanin receptor 1 (GalR1).</p></disp-quote><p>We also agree, that a more regional approach, after having more reliable information on the expression domains of the different galanin receptors, including more information on their respective role, is an important future research direction.</p><disp-quote content-type="editor-comment"><p>The description of the EAAT2 mutants is missing crucial details. EAAT2 plays a significant role in the uptake of glutamate from the synaptic cleft, thereby regulating excitatory neurotransmission and preventing excitotoxicity. Authors suggest that in EAAT2 knockout (KO) mice galanin expression is upregulated 15-fold compared to wild-type (WT) mice, which could be interpreted as galanin playing a role in the hypoactivity observed in these animals.</p><p>However, the study does not explore the misregulation of other genes that could be contributing to the observed phenotype. For instance, if AMPA receptors are significantly downregulated, or if there are alterations in other genes critical for brain activity, these changes could be more important than the upregulation of galanin. The lack of wider gene expression analysis leaves open the possibility that the observed hypoactivity could be due to factors other than, or in addition to, galanin upregulation.</p></disp-quote><p>We are in the process of preparing a manuscript describing a more detailed gene expression study of this and a chemically induced seizure model. Surprisingly we did not observe strong effects on glutamate receptor related genes. This does not preclude and indeed we deem it likely that additional factors play a role, e.g. other neuropeptides.</p><disp-quote content-type="editor-comment"><p>Moreover, the observation that in double KO mice for both EAAT2 and galanin there was little difference in seizure susceptibility compared to EAAT2 KO mice alone further supports the idea that galanin upregulation might not be the reason to the observed phenotype. This indicates that other regulatory mechanisms or gene expressions might be playing a more pivotal role in the manifestation of hypoactivity in EAAT2 mutants.</p></disp-quote><p>Yes, we agree that galanin is likely not the only player. This warrants further investigations.</p><disp-quote content-type="editor-comment"><p>These methodological shortcomings and conceptual inconsistencies undermine the perceived strengths of the study, and hinders understanding of Galanin's role in epilepsy and stress regulation.</p><p><bold>Review 2:</bold></p><p>Previous concerns about sex or developmental biological variables were addressed, as their model's seizure phenotype emerges rapidly and long prior to the establishment of zebrafish sexual maturity. However, in the course of re-review, some additional concerns (below) were detected that, if addressed, could further improve the manuscript. These concerns relate to how seizures were defined from the measurement of fluorescent calcium imaging data. Overall, this study is important and convincing, and carries clear value for understanding the multifaceted functions that neuronal galanin can perform under homeostatic and disease conditions.</p></disp-quote><p>We are pleased that we could dispel the initial concerns.</p><disp-quote content-type="editor-comment"><p>Additional Concerns:</p><p>- The authors have validated their ability to measure behavioral seizures quantitatively in their 2022 Glia paper but the information provided on defining behavioral seizures was limited. The definition of behavioral seizure activity is not expanded upon in this paper, but could provide detail about how the behavioral seizures relate to a seizure detected via calcium imaging.</p></disp-quote><p>In this paper we indeed do not address behavioral seizures but focus completely on neuronal seizures as defined in the material and methods section (“seizures were defined as calcium fluctuations reaching at least 100% of ΔF/F0 in the whole brain.”). Epileptic seizures in zebrafish, either evoked by pharmacological means or the result of genetic mutations, evoke stereotyped locomotor behavior in zebrafish as described in multiple publications (e.g. Baraban et al., 2005, Berghmans et al., 2007, Baxendale et al., 2012 and references therein).</p><disp-quote content-type="editor-comment"><p>- Related to the previous point, for the calcium imaging, the difference between an increase in fluorescence that the authors think reflects increased neuronal activity and the fluorescence that corresponds to seizures is not very clear. This detail is necessary because exactly when the term &quot;seizure&quot; describes a degree of increased activity can be difficult to distinguish objectively.</p></disp-quote><p>In our material and methods section, we describe our working definition of a seizure. Seizures are easily distinguished from increased activity by being synchronized.</p><disp-quote content-type="editor-comment"><p>- The supplementary movies that were added were very useful, but raised some questions. For example, what brain regions were pulsating? What areas seemed to constantly exhibit strong fluorescence and was this an artifact? It seemed that sometimes there was background fluorescence in the body. Perhaps an anatomical diagram could be provided for the readers. In addition, there were some movies with much greater fluorescence changes - are these the seizures? These are some reasons for our request for clarified definitions of the term &quot;seizure&quot;.</p></disp-quote><p>The ”pulsating” (or “flickering”) brain activity is spontaneous neuronal activity. Some areas may appear to be more active, probably by a denser packing of neurons and intrinsically more spontaneous neuronal activity. However, since we only use normalized data, this does not affect our measurements.</p><disp-quote content-type="editor-comment"><p>- While it is not critical to change, I will again note the possible confusion that the use of the word &quot;sedative&quot; in this context may cause. However, I do understand this is a stylistic choice.</p><p>- Supplementary Figure 1B: the N values along the x-axis appear to have been duplicated and the duplications are offset and overlapping with one another by mistake.</p></disp-quote><p>Thank you for pointing this out. We have corrected the figure accordingly.</p><disp-quote content-type="editor-comment"><p><bold>Review 3:</bold></p><p>(1) Although the relationship between galanin and brain activity during interictal or seizure-free periods was clear, the revised manuscript still lacks mechanistic insight in the role of galanin during seizure-like activity induced by PTZ.</p></disp-quote><p>We agree that the mechanistic role of galanin still needs to be defined. The role is more complex that we expected, mainly due to its negative feedback properties. A complete mechanistic understanding will require a number of additional studies and is unfortunately outside of the scope of this manuscript.</p><disp-quote content-type="editor-comment"><p>(2) The revised manuscript continues to heavily rely on calcium imaging of different mutant lines. Confirmation of knockouts has been provided with immunostaining in a new supplementary figure. Additional methods could strengthen the data, translational relevance, and interpretation (e.g., acute pharmacology using galanin agonists or antagonists, brain or cell recordings, biochemistry, etc).</p></disp-quote><p>Cell recordings and biochemistry is challenging in the small larval zebrafish brain. We deem the genetic manipulations that we describe to be more informative than pharmacological experiments due to specificity issues.</p></body></sub-article></article>